<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Deliv Transl Res</journal-id><journal-id journal-id-type="iso-abbrev">Drug Deliv Transl Res</journal-id><journal-title-group><journal-title>Drug Delivery and Translational Research</journal-title></journal-title-group><issn pub-type="ppub">2190-393X</issn><issn pub-type="epub">2190-3948</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7097340</article-id><article-id pub-id-type="pmid">31788762</article-id><article-id pub-id-type="publisher-id">691</article-id><article-id pub-id-type="doi">10.1007/s13346-019-00691-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ben-Shabat</surname><given-names>Shimon</given-names></name><address><email>sbs@bgu.ac.il</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yarmolinsky</surname><given-names>Ludmila</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Porat</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3498-3514</contrib-id><name><surname>Dahan</surname><given-names>Arik</given-names></name><address><email>arikd@bgu.ac.il</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.7489.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0511</institution-id><institution>Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, </institution><institution>Ben-Gurion University of the Negev, </institution></institution-wrap>8410501 Beer-Sheva, Israel </aff><aff id="Aff2"><label>2</label>Eastern R&#x00026;D Center, Kiryat Arba, Israel </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>10</volume><issue>2</issue><fpage>354</fpage><lpage>367</lpage><permissions><copyright-statement>&#x000a9; Controlled Release Society 2019</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Viral infections affect three to five million patients annually. While commonly used antivirals often show limited efficacy and serious adverse effects, herbal extracts have been in use for medicinal purposes since ancient times and are known for their antiviral properties and more tolerable side effects. Thus, naturally based pharmacotherapy may be a proper alternative for treating viral diseases. With that in mind, various pharmaceutical formulations and delivery systems including micelles, nanoparticles, nanosuspensions, solid dispersions, microspheres and crystals, self-nanoemulsifying and self-microemulsifying drug delivery systems (SNEDDS and SMEDDS) have been developed and used for antiviral delivery of natural products. These diverse technologies offer effective and reliable delivery of medicinal phytochemicals. Given the challenges and possibilities of antiviral treatment, this review provides the verified data on the medicinal plants and related herbal substances with antiviral activity, as well as applied strategies for the delivery of these plant extracts and biologically active phytochemicals.</p><p id="Par2">
<fig position="anchor" id="Figa"><caption><p>Graphical Abstract</p></caption><graphic position="anchor" xlink:href="13346_2019_691_Figa_HTML" id="MO1"/></fig>
</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Antiviral</kwd><kwd>Phytomedicine</kwd><kwd>Herbal extracts</kwd><kwd>Flavonoid</kwd><kwd>Solubility</kwd><kwd>Oral drug delivery</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Controlled Release Society 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par3">Viral infections remain a major worldwide cause of morbidity and mortality. Among the most aggressive viral infections are Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS (severe acute respiratory syndrome). For instance, influenza is responsible for over 3 million new cases of severe disease, and between 300,000&#x02013;500,000 deaths yearly [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Alarmingly, the number of patients diagnosed with viral infections is increasing every year with more blood transfusions, organ transplantations, and the use of hypodermic syringes.</p><p id="Par4">Classic antiviral drugs such as interferon and ribavirin are effective <italic>in vitro</italic> against most viruses, but often are ineffective in patients. Ninety different antiviral agents available today [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>] only treat a selection of viruses; these viruses include HIV (human immunodeficiency virus), herpes viruses, including HSV (herpes simplex virus), hCMV (human cytomegalovirus), VZV (varicella zoster virus), influenza viruses, and the hepatitis viruses (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Currently, there is no approved remedy for many types or viruses, and vaccination is limited to hepatitis A virus, mumps, and varicella [<xref ref-type="bibr" rid="CR2">2</xref>]. In addition, these agents are often costly and ineffective due to viral resistance and cause side effects. With that in mind, naturally based pharmacotherapy may be a proper alternative for treating viral diseases. Thus, it is necessary to further examine the topic of antiviral phytochemicals, highlighting drug delivery applications in overcoming the multiple biological barriers existing for antiviral agents to successfully reach their intended site(s) of action. The present review focuses on the antiviral properties of herb extracts and bioactive constituent isolates from medicinal plants, and the efforts to obtain their efficient delivery.<fig id="Fig1"><label>Fig. 1</label><caption><p>Antiviral drugs. The antiviral drugs are used for HIV (human immunodeficiency virus), herpes viruses, influenza A and B viruses, and the HBV (hepatitis B) and HCV (hepatitis C) viruses. Some of the commonly prescribed antiviral drugs are given. NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor</p></caption><graphic xlink:href="13346_2019_691_Fig1_HTML" id="MO2"/></fig></p></sec><sec id="Sec2"><title>Antiviral medicinal plants and phytochemicals</title><p id="Par5">Various plants have been used in medicine since ancient times and are known for their strong therapeutic effect. In traditional medicine, diseases of possible viral origin have been treated by many of these plants. The main findings related to antiviral plant extracts are collected in Table <xref rid="Tab1" ref-type="table">1</xref>. Included extracts were tested in cell culture, and some extracts were also studied <italic>in vivo</italic> [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR39">39</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Antiviral properties of plant extracts</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Plant</th><th>Kind of extract</th><th>Virus</th><th>Phytochemicals</th><th>References</th></tr></thead><tbody><tr><td><italic>Achillea fragrantissima</italic></td><td>Hydro-alcoholic extract</td><td>Poliomyelitis-1 virus (POLIO)</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td><italic>Aegle marmelos</italic></td><td>Aqueous extract</td><td>Human coxsackieviruses B1-B6</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR4">4</xref>]</td></tr><tr><td><italic>Aloe vera</italic></td><td>Glycerine extract</td><td>HSV-2</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td><italic>Artocarpus integrifolia</italic></td><td>Aqueous extract</td><td>(SA-11) and human (HCR3) rotaviruses</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Balanites aegyptiaca</italic></td><td>n-Hexane extract</td><td>VSV T2</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR7">7</xref>]</td></tr><tr><td><italic>Camellia sinensis</italic></td><td>Aqueous extracts</td><td>HBV</td><td>Epigallocathechin-3-gallate</td><td>[<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td><italic>Capparis spinosa</italic></td><td>Methanolic extract</td><td><p>HSV-2</p><p>HIV-1</p></td><td><p>Unknown</p><p>Protein</p></td><td>[<xref ref-type="bibr" rid="CR9">9</xref>]</td></tr><tr><td><italic>Cassine xylocarpa</italic></td><td>Aqueous extract</td><td>HIV</td><td>Pentacyclic lupane-type triterpenoids</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td><italic>Cistus incanus</italic></td><td>Polyphenol-rich extract (CYSTUS052)</td><td><p>Avian and human influenza strains of different subtypes</p><p>HIV-1 and HIV-2</p></td><td><p>Unknown</p><p>Unknown</p></td><td><p>[<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]</p><p>[<xref ref-type="bibr" rid="CR13">13</xref>]</p></td></tr><tr><td><italic>Curcuma longa</italic></td><td>Aqueous extract</td><td>HSV-1</td><td>Curcumin</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td><italic>Cyperus rotundus</italic></td><td>Hydro-alcoholic extract</td><td><p>HSV-1</p><p>HBV</p></td><td><p>Unknown</p><p>cyperene-3, 8-dione, 14-hydroxy cyperotundone, 14-acetoxy cyperotundone, 3&#x003b2;-hydroxycyperenoic acid and sugetriol-3, 9-diacetate</p></td><td>[<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td><italic>Daphne gnidium</italic></td><td>Hydro-alcoholic extract</td><td>HIV</td><td>Daphnetoxin, gnidicin, gniditrin and excoecariatoxin</td><td>[<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td><italic>Diospyros kaki</italic></td><td>Aqueous extract</td><td>Human rotavirus</td><td>Licocoumarone, licoflavonol, glyasperin D, 18 &#x003b2;-glycyrrhetinic acid, luteolin, vitexin, apigenin-7-O-glucoside</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Dittrichia viscosa</italic></td><td>Aqueous extract</td><td>VSV, HSV-1, poliovirus type 1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td><italic>Euphorbia hirta</italic></td><td>Aqueous extracts, methanol extracts</td><td>HIV-1, HIV-2, SIV mac 251</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td><italic>Euphorbia spinidens</italic></td><td>Methanol extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td><italic>Ficus benjamina</italic></td><td>Ethanol extract</td><td>HSV-1, HSV-2</td><td>Rutin, kaempferol 3-O-rutinoside and kaempferol 3-O-robinobioside</td><td>[<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td><italic>Ficus carica</italic></td><td><p>Aqueous extract</p><p>The hexanic and hexane-ethyl acetate from latex of fig fruit</p><p>Hexanic extract</p></td><td><p>HSV-1</p><p>HSV-1, ECV-11 and ADV</p><p>influenza virus</p></td><td>Unknown</td><td><p>[<xref ref-type="bibr" rid="CR19">19</xref>]</p><p>[<xref ref-type="bibr" rid="CR20">20</xref>]</p><p>[<xref ref-type="bibr" rid="CR21">21</xref>]</p></td></tr><tr><td><italic>Globularia arabica</italic></td><td>Hydro-alcoholic extract</td><td>Poliomyelitis-1 virus (POLIO)</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td><italic>Glycyrrhiza glabra</italic></td><td>Methanolic extract</td><td>NDV</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td><italic>Glycyrrhiza uralensis</italic></td><td>Metabolic extract</td><td>Rotavirus diarrhea</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td><italic>Hyssopus officinalis</italic></td><td>Methanolic extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td><italic>Leucojum vernum</italic></td><td>Methanolic extract</td><td>HIV-1</td><td>Homolycorine and 2-O-acetyllycorine</td><td>[<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr><tr><td><italic>Lilium candidum</italic></td><td>Ethanol extract</td><td>HSV-1, HSV-2</td><td>Kaempferol</td><td>[<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td><italic>Magnolia officinalis</italic></td><td>Methanol extract</td><td>Dengue virus Type 2</td><td>Honokiol</td><td>[<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td><italic>Maytenus cuzcoina</italic></td><td>Aqueous extract</td><td>HIV</td><td>Pentacyclic lupane-type triterpenoids</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td><italic>Melissa officinalis</italic></td><td>Aqueous extract</td><td><p>HSV-1</p><p>HSV-1, HSV-2</p><p>HIV</p></td><td>Unknown</td><td><p>[<xref ref-type="bibr" rid="CR27">27</xref>]</p><p>[<xref ref-type="bibr" rid="CR28">28</xref>]</p><p>[<xref ref-type="bibr" rid="CR29">29</xref>]</p></td></tr><tr><td><italic>Mentha pulegium</italic></td><td>Methanolic extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td><italic>Moringa peregrina</italic></td><td>Hydro-alcoholic extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td><italic>Myristica fragrans</italic></td><td>Aqueous extract</td><td>Human rotavirus</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Olea europaea</italic></td><td>Hexanic extract</td><td>Influenza virus subtype H9N2</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td><italic>Panax ginseng</italic></td><td>Methanolic extract</td><td>Human rotavirus</td><td>Epigallocatechin gallate, theaflavin digallate, genistein, hesperidin, neohesperidin, diosmin, pectic polysaccharides</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Panax notoginseng</italic></td><td>Aqueous extract</td><td>Influenza A virus</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td><italic>Phyllanthus acidus</italic></td><td>Aqueous extract</td><td>HBV</td><td>Highly oxygenated norbisabolane sesquiterpenoids, phyllanthacidoid acid methyl ester</td><td>[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td><italic>Phyllanthus emblica</italic></td><td><p>Aqueous extract</p><p>Aqueous extract</p></td><td><p>Influenza A virus strain H3N2</p><p>HBV</p></td><td><p>Highly oxygenated norbisabolane sesquiterpenoids</p><p>Sesquiterpenoid glycoside dimers</p></td><td><p>[<xref ref-type="bibr" rid="CR33">33</xref>]</p><p>[<xref ref-type="bibr" rid="CR34">34</xref>]</p></td></tr><tr><td><italic>Prunella vulgaris</italic></td><td>Aqueous extract</td><td><p>HIV-1</p><p>Ebola virus</p></td><td>Unknown</td><td><p>[<xref ref-type="bibr" rid="CR35">35</xref>]</p><p>[<xref ref-type="bibr" rid="CR36">36</xref>]</p></td></tr><tr><td><italic>Quercus brantii L Acorn.</italic></td><td>Ethanol extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td><italic>Quercus persica</italic></td><td>Hydroalchoholic extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td><italic>Salacia reticulata</italic></td><td>Aqueous extract</td><td>H1N1 influenza</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td><italic>Sanguisorba minor</italic></td><td>Aqueous extract</td><td><p>VSV, HSV-1</p><p>HIV</p></td><td/><td><p>[<xref ref-type="bibr" rid="CR16">16</xref>]</p><p>[<xref ref-type="bibr" rid="CR40">40</xref>]</p></td></tr><tr><td><italic>Securigera securidaca</italic></td><td>Methanol extract</td><td>HSV-1, HSV-2</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td><italic>Solanum nigrum</italic></td><td>Methanol and chloroform extracts of seeds</td><td>HCV</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td><italic>Spondias lutea</italic></td><td>Aqueous extract</td><td>Human rotavirus</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Tamarix nilotica</italic></td><td>Hydro-alcoholic extract</td><td>HSV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td><italic>Taraxacum officinale</italic></td><td><p>Methanol extract</p><p>Aqueous extract</p></td><td><p>HCV</p><p>Influenza virus type A, H1N1.</p></td><td>Unknown</td><td><p>[<xref ref-type="bibr" rid="CR42">42</xref>]</p><p>[<xref ref-type="bibr" rid="CR43">43</xref>]</p></td></tr><tr><td><italic>Thymus carmanicus</italic></td><td>Methanol extract</td><td>HIV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td><italic>Thymus daenensis</italic></td><td>Methanol extract</td><td>HIV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td><italic>Thymus kotschyanus</italic></td><td>Methanol extract</td><td>HIV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td><italic>Thymus vulgaris</italic></td><td>Methanol extract</td><td>HIV-1</td><td>Unknown</td><td>[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td><italic>Tuberaria lignosa</italic></td><td>An aqueous extract</td><td>HIV</td><td>Ellagic acid derivative</td><td>[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td><italic>Viola diffusa</italic></td><td>Ethanol extract</td><td>HBV</td><td>2&#x003b2;-hydroxy-3, 4-seco-friedelolactone-27-oic acid, 2&#x003b2;, 28&#x003b2;-dihydroxy-3,4-seco-friedelolactone-27-oic acid, 2&#x003b2;, 30&#x003b2;-dihydroxy-3,4-seco-friedelolactone-27-lactone and stigmastane, stigmast-25-ene-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol</td><td>[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td><italic>Vitis labrusca</italic></td><td>Methanol extract</td><td>(SA-11) and human (HCR3) rotaviruses</td><td>Resveratrol, piceatannol, trans-arachidin-1 and trans-arachidin-3</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Vitis macrocarpon</italic></td><td>Methanol extract</td><td>(SA-11) and human (HCR3) rotaviruses</td><td>Abietic acid, all-trans-retinoic acid, mangostin, &#x003b1;-glucosyl hesperidin, proanthocyanidins</td><td>[<xref ref-type="bibr" rid="CR6">6</xref>]</td></tr><tr><td><italic>Zataria multiflora</italic></td><td>Methanolic extract</td><td>HSV-1</td><td>Rosmarinic acid</td><td>[<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>HSV</italic> herpes simplex virus, <italic>VSV</italic> vesicular stomatitis virus, <italic>HBV</italic> hepatitis B virus, <italic>HIV</italic> human immunodeficiency virus, <italic>SIV</italic> simian immunodeficiency virus, <italic>ECV</italic> echovirus, <italic>ADV</italic> adenovirus, <italic>NDV</italic> Newcastle disease virus, <italic>HCV</italic> hepatitis C virus</p></table-wrap-foot></table-wrap></p><p id="Par6">Various phytochemicals were isolated, purified, and identified from the crude extracts of alkaloids, terpenes, flavonoids, various glycosides, and proteins (Table <xref rid="Tab1" ref-type="table">1</xref>). Compounds with antiviral activity are present in many plants, e.g., rutin, a flavonoid glycoside common in different plants, is effective against avian influenza virus [<xref ref-type="bibr" rid="CR48">48</xref>], HSV-1, HSV-2 [<xref ref-type="bibr" rid="CR18">18</xref>], and parainfluenza-3 virus [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par7">Quercetin, an aglycone of rutin, is a phytochemical abundant in plants and may diminish the replication of many viruses: highly pathogenic influenza virus [<xref ref-type="bibr" rid="CR50">50</xref>], rhinovirus [<xref ref-type="bibr" rid="CR51">51</xref>], dengue virus type-2 [<xref ref-type="bibr" rid="CR52">52</xref>], HSV-1 [<xref ref-type="bibr" rid="CR53">53</xref>], poliovirus [<xref ref-type="bibr" rid="CR54">54</xref>], adenovirus [<xref ref-type="bibr" rid="CR53">53</xref>], Epstein-Barr virus [<xref ref-type="bibr" rid="CR55">55</xref>], Mayaro virus [<xref ref-type="bibr" rid="CR56">56</xref>], Japanese encephalitis virus [<xref ref-type="bibr" rid="CR57">57</xref>], respiratory syncytial virus [<xref ref-type="bibr" rid="CR58">58</xref>], and HCV [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Its antiviral activity mode was studies in a few cases. Its ability to inhibit HCV by limiting the activity of some heat shock proteins (HSPs) produced by cells in response to exposure to stress which were involved in NS5A (nonstructural protein 5A)-mediated viral IRES (internal ribosome entry site) translation [<xref ref-type="bibr" rid="CR60">60</xref>] is one well-known mechanism. Another mechanism involved the inhibition of HCV NS3 protease and HCV replication in a sub-genomic HCV RNA replicon cell system [<xref ref-type="bibr" rid="CR59">59</xref>]. Quercetin also inhibits various steps of the rhinoviruses pathogenesis, i.e., endocytosis, viral genome transcription, and protein synthesis [<xref ref-type="bibr" rid="CR51">51</xref>]. In another case, quercetin was shown to have a more specific mode of action, reducing the replication of dengue virus type-2, but not the processes of viral attachment and entry [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par8">In addition, quercetin and three other flavonoids: 3,3&#x02032;,4&#x02032;,5,5&#x02032;,7-hexahydroxyflavone (myricetin), 3,3&#x02032;,4&#x02032;,5,6,7-hexahydroxyflavone (quercetagetin), and 5,6,7-trihydroxyflavone (baicalein), all effectively inhibited reverse transcriptases from Rauscher murine leukemia virus (RLV) and HIV; quercetin, myricetin, and quercetagetin were also shown to inhibit different DNA polymerase enzymes [<xref ref-type="bibr" rid="CR61">61</xref>]. The abovementioned flavonoid, myricetin, is abundant in wild plants, nuts, fruits, berries, and vegetables. Ellagic acid and myricetin (from the aronia fruit) were active in cell cultures against different subtypes of influenza viruses including an oseltamivir-resistant strain, and also effective <italic>in vivo</italic> [<xref ref-type="bibr" rid="CR62">62</xref>].</p><p id="Par9">Apigenin (4&#x02032;,5,7-trihydroxyflavone), an aglycone of the flavone class, is found in many plants and has broad antiviral activities against enterovirus-71 [<xref ref-type="bibr" rid="CR63">63</xref>], foot and mouth disease virus [<xref ref-type="bibr" rid="CR64">64</xref>], HCV [<xref ref-type="bibr" rid="CR65">65</xref>], African swine fever virus (ASFV) [<xref ref-type="bibr" rid="CR66">66</xref>], and influenza A virus [<xref ref-type="bibr" rid="CR67">67</xref>]. Of note, many flavonoids of plant origin have known antiviral properties. For example, out of 22 different flavonoids, six phytochemicals (apigenin, baicalein, biochanin A, kaempferol, luteolin, naringenin) were active against the avian influenza H5N1 virus in human lung epithelial (A549) cells through inhibiting nucleoprotein production [<xref ref-type="bibr" rid="CR67">67</xref>]. Baicalin (the glucuronide of baicalein) was also active against a wide range of viruses, including enterovirus [<xref ref-type="bibr" rid="CR68">68</xref>], dengue virus [<xref ref-type="bibr" rid="CR69">69</xref>], respiratory syncytial virus [<xref ref-type="bibr" rid="CR70">70</xref>], Newcastle disease virus [<xref ref-type="bibr" rid="CR71">71</xref>], human immunodeficiency virus [<xref ref-type="bibr" rid="CR72">72</xref>], and hepatitis B virus [<xref ref-type="bibr" rid="CR73">73</xref>], and different mechanisms were suggested for its antiviral actions. For example, baicalin inhibits the production of HBV, the templates for viral proteins and HBV-DNA synthesis [<xref ref-type="bibr" rid="CR73">73</xref>], and decreases IL-6 and IL-8 production without affecting IP-10 levels, as shown in a study on avian influenza H5N1 virus [<xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par10">The triterpenoids oleanolic acid and ursolic acid are abundant in the plant kingdom, may be effective against HCV by reducing HCV NS5B RdRp virulence [<xref ref-type="bibr" rid="CR74">74</xref>], and can also inhibit enterovirus 71 replication [<xref ref-type="bibr" rid="CR75">75</xref>]. Lastly, <italic>Sambucus nigra</italic> L. is an active ingredient in a standardized elderberry extract, effectively used in the treatment of fever, colds, and influenza A and B [<xref ref-type="bibr" rid="CR76">76</xref>&#x02013;<xref ref-type="bibr" rid="CR78">78</xref>].</p></sec><sec id="Sec3"><title>Delivery of herbal extracts and phytochemicals</title><p id="Par11">Introducing pharmaceutical nanotechnology into the field of natural medicine is useful and promising. New strategies for the delivery of poorly soluble phytochemicals and plant extracts allow improved pharmacokinetic and clinical outcomes. Commonly used approached such as phytosomes, nanoparticles, hydrogels, microspheres, transferosomes and ethosomes, self-microemulsifying drug delivery systems (SMEDDS), and self-nanoemulsifying drug delivery systems (SNEDDS) have been applied for the delivery of antiviral plant agents (Table <xref rid="Tab2" ref-type="table">2</xref>). These antiviral technologies may be preferred over older phytochemical drug formulations due to enhanced solubility and oral absorption, systemic bioavailability, safety, delayed metabolism, and better overall antiviral activity. Yet, very few papers have been published on the topic of antiviral herbal drug delivery, so we wish to display several successful attempts of improving the delivery of phytodrugs with known antiviral activity. Qian et al. [<xref ref-type="bibr" rid="CR79">79</xref>] attempted to design a self-nanoemulsifying drug delivery system (SNEDDS) to allow greater apparent solubility and oral bioavailability (&#x0003c; 10%) of myricetin. Overall, four formulations were prepared, F04 (Capryol 90/Cremophor RH 40/PEG 400 in a 4:3:3 ratio), F08 (Capryol 90/Cremophor RH 40/1,2-propanediol 4:3:3), F13 (Capryol 90/Cremophor EL/Transcutol HP 4:3:3), and F15 (Capryol 90/Cremophor RH 40/Transcutol HP 2:7:1), and the solubility of myricetin in different excipients was studied. The optimized formulations underwent evaluation of release (dissolution), Caco-2 cell cytotoxicity and intestinal permeability studies <italic>in vitro</italic>, following by <italic>in vivo</italic> pharmacokinetics of myricetin-SNEDDS. Three of the four chosen formulations exhibited acceptable cell viability (&#x0003e; 90%), while the fourth formulation was slightly cell-toxic, probably because of high nonionic surfactant content (70%). <italic>In vitro</italic> drug release testing demonstrated that myricetin alone had limited dissolution of 51% after an hour, whereas drug release for all SNEDDS formulations was over 90% after 1 min. Single-pass intestinal perfusion (SPIP) method in rats showed that in the duodenum, the primary absorption site of myricetin, the effective permeability coefficient was significantly higher (1.2&#x02013;2.2-fold, <italic>p</italic> &#x0003c; 0.05) in all SNEDDS formulations relative to free myricetin, via inhibition of myricetin efflux by nonionic surfactants in SNEDDS (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). In animal models, the myricetin-loaded SNEDDS formulations exhibited higher plasma myricetin concentrations in all time points compared to the free myricetin. Formulation No. 13 in Fig. <xref rid="Fig2" ref-type="fig">2</xref> had higher intestinal permeability, but showed lower bioavailability attributed to poor lymphatic transport&#x02014;a main absorption mechanism of myricetin. Formulation No. 4 and 8, on the other hand, achieved small particle size, required for lymphatic transport (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of the different applied delivery systems for antiviral phytochemicals</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Phytochemical</th><th>Viruses</th><th>Delivery system/method</th></tr></thead><tbody><tr><td>Myricetin</td><td>HIV, RLV, influenza</td><td>SNEDDS [<xref ref-type="bibr" rid="CR79">79</xref>], nanogel [<xref ref-type="bibr" rid="CR80">80</xref>], mixed micelles [<xref ref-type="bibr" rid="CR81">81</xref>], nanosuspension [<xref ref-type="bibr" rid="CR82">82</xref>], cocrystal [<xref ref-type="bibr" rid="CR83">83</xref>], nanoencapsulation [<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td>Apigenin</td><td>Enterovirus 71, FMDV, HCV, ASFV, influenza A</td><td>W/O/W emulsion [<xref ref-type="bibr" rid="CR85">85</xref>], O/W microemulsion [<xref ref-type="bibr" rid="CR86">86</xref>], solid dispersion [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], mixed micelles [<xref ref-type="bibr" rid="CR89">89</xref>], phospholipid phytosome [<xref ref-type="bibr" rid="CR90">90</xref>], pellets [<xref ref-type="bibr" rid="CR91">91</xref>], SMEDDS [<xref ref-type="bibr" rid="CR92">92</xref>]</td></tr><tr><td>Baicalin</td><td>Influenza, NDV, enterovirus 71, DENV, RSV, HIV, HBV</td><td>Liposome [<xref ref-type="bibr" rid="CR93">93</xref>], mixed micelles [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>], polymeric micelles [<xref ref-type="bibr" rid="CR96">96</xref>], SNEDDS [<xref ref-type="bibr" rid="CR97">97</xref>], nanoemulsion [<xref ref-type="bibr" rid="CR98">98</xref>], inclusion complex [<xref ref-type="bibr" rid="CR99">99</xref>], solid dispersion [<xref ref-type="bibr" rid="CR100">100</xref>], nanoparticles [<xref ref-type="bibr" rid="CR101">101</xref>], nanocrystals [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>], SMEDDS [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td>Quercetin</td><td>JEV, influenza A, EBV, MAYV, RV, HCV</td><td>Nanocrystal [<xref ref-type="bibr" rid="CR105">105</xref>], nanoparticles [<xref ref-type="bibr" rid="CR106">106</xref>&#x02013;<xref ref-type="bibr" rid="CR110">110</xref>], phytosome [<xref ref-type="bibr" rid="CR111">111</xref>], nanoliposome [<xref ref-type="bibr" rid="CR112">112</xref>], mixed micelles [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>], SNEDDS [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>], nanocarrier [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>], nanoemulsion [<xref ref-type="bibr" rid="CR119">119</xref>], nanosuspension [<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td><italic>Fructus Forsythiae extracts</italic></td><td>Influenza, RSV</td><td>chito-oligosaccharide [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td><italic>Flos Lonicerae extracts</italic></td><td>Influenza, RSV, HIV, NDV</td><td>chito-oligosaccharide [<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>Andrographolide</td><td>DENV, CHIKV, HPV16 pseudovirus, influenza, HBV, HCV, HSV1, EBV, HIV</td><td>SMEDDS [<xref ref-type="bibr" rid="CR123">123</xref>], microspheres [<xref ref-type="bibr" rid="CR124">124</xref>], nanosuspension [<xref ref-type="bibr" rid="CR125">125</xref>], self-nanodispersion [<xref ref-type="bibr" rid="CR126">126</xref>], nanoparticles [<xref ref-type="bibr" rid="CR127">127</xref>], inclusion complex [<xref ref-type="bibr" rid="CR128">128</xref>]</td></tr><tr><td>Curcumin</td><td>Influenza, RSV, HBV, HCV, ZIKV, CHIKV, norovirus, HIV, HPV, CMV, EV71, DENV type-2</td><td>Mixed micelles [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>], nanoparticles [<xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>], solid dispersion [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>] , SNEDDS [<xref ref-type="bibr" rid="CR135">135</xref>] , SMEDDS [<xref ref-type="bibr" rid="CR136">136</xref>], lipid carrier [<xref ref-type="bibr" rid="CR137">137</xref>], copolymeric micelles [<xref ref-type="bibr" rid="CR138">138</xref>], exosomes [<xref ref-type="bibr" rid="CR139">139</xref>]</td></tr><tr><td>Naringenin</td><td>DENV, HCV</td><td>SNEDDS [<xref ref-type="bibr" rid="CR140">140</xref>], solid dispersion [<xref ref-type="bibr" rid="CR141">141</xref>], nanoparticles [<xref ref-type="bibr" rid="CR142">142</xref>, <xref ref-type="bibr" rid="CR143">143</xref>] , liposome [<xref ref-type="bibr" rid="CR144">144</xref>], nanosuspension [<xref ref-type="bibr" rid="CR145">145</xref>, <xref ref-type="bibr" rid="CR146">146</xref>] , cyclodextrin complex [<xref ref-type="bibr" rid="CR147">147</xref>]</td></tr><tr><td>Honokiol</td><td>DENV, HCV</td><td>Inclusion complex [<xref ref-type="bibr" rid="CR148">148</xref>], conjugate micelles [<xref ref-type="bibr" rid="CR149">149</xref>], nanoparticles [<xref ref-type="bibr" rid="CR150">150</xref>]</td></tr><tr><td>Oleanolic acid</td><td>Acute and chronic hepatitis</td><td>SMEDDS [<xref ref-type="bibr" rid="CR151">151</xref>], nanoparticles [<xref ref-type="bibr" rid="CR152">152</xref>], nanosuspensions [<xref ref-type="bibr" rid="CR153">153</xref>, <xref ref-type="bibr" rid="CR154">154</xref>] , SNEDDS [<xref ref-type="bibr" rid="CR155">155</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>HIV</italic> human immunodeficiency virus, <italic>RLV</italic> rhesus lymphocryptovirus, <italic>FMDV</italic> foot and mouth disease virus, <italic>HCV</italic> hepatitis C virus, <italic>ASFV</italic> African swine fever virus, <italic>NDV</italic> Newcastle disease virus, <italic>DENV</italic> dengue virus, <italic>RSV</italic> respiratory syncytial virus, <italic>HBV</italic> hepatitis B virus, <italic>JEV</italic> Japanese encephalitis virus, <italic>EBV</italic> Epstein&#x02013;Barr virus, <italic>MAYV</italic> Mayaro virus, <italic>RV</italic> rhinovirus, <italic>CHIKV</italic> Chikungunya virus, <italic>HPV</italic> human papilloma virus, <italic>HSV</italic> herpes simplex virus, <italic>ZIKV</italic> Zika virus, <italic>CMV</italic> cytomegalovirus, <italic>EV</italic> enterovirus, <italic>SNEDDS</italic> self-nanoemulsifying drug delivery system, <italic>W/O/W</italic> water-in-oil-in-water, <italic>O/W</italic> oil-in-water, <italic>SMEDDS</italic> self-microemulsifying drug delivery system</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Myricetin blood levels in rats after oral administration of 20 mg/kg free myricetin or any of four different SNEDDS formulations (<italic>n</italic> = 6); upper right: permeability coefficient (<italic>P</italic><sub>eff</sub>) of myricetin in single-pass intestinal perfusion model (<italic>n</italic> = 3); F04, Capryol 90/Cremophor RH 40/PEG 400 4:3:3; F08, Capryol 90/Cremophor RH 40/1,2-propanediol 4:3:3; F13, Capryol 90/Cremophor EL/Transcutol HP 4:3:3 and F15, Capryol 90/Cremophor RH 40/Transcutol HP 2:7:1. Reproduced from [<xref ref-type="bibr" rid="CR79">79</xref>] with permission</p></caption><graphic xlink:href="13346_2019_691_Fig2_HTML" id="MO3"/></fig></p><p id="Par12">Kim et al. [<xref ref-type="bibr" rid="CR85">85</xref>] tried to increase the oral bioavailability of the low solubility flavonoid apigenin. Different water-in-oil-in-water emulsions of apigenin were studied for their physical characteristics, as well as digestibility using <italic>in vitro</italic> digestion model and <italic>in vivo</italic> pharmacokinetics in rats. An emulsion of soybean oil-Tween 80 was chosen for pharmacokinetic tests in animal model after proving better stability in terms of particle size and zeta potential. Plasma concentrations of apigenin in the water-in-oil emulsion were markedly higher at different time points and maximal concentration was 9-fold higher compared to apigenin suspension [<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par13">Zhang et al. [<xref ref-type="bibr" rid="CR94">94</xref>] aimed to improve the oral absorption of baicalin, which has low solubility and poor permeability, by using a micellar formulation comprised of the carriers Pluronic P123 copolymer and sodium taurocholate. Sustained release profile of baicalin-loaded mixed micelles, in <italic>in vitro</italic> drug release experiment, held in several pH conditions, showed 14% drug released after 2 h in gastric conditions and 54% release within 48 h in intestinal conditions, compared to 34% and 79% release from a baicalin suspension, respectively. This observation suggests improved stability afforded by the designed formulation. <italic>In vitro</italic> uptake studies, carried out with a caco-2 cell line, determined the absorption of baicalin within the mixed micelles and verified their internalization ability. Baicalin-loaded ST-P123-MMs formulation achieved high oral bioavailability (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). These results are believed to derive from the micellar small size and to Pluronic component, which is a P-glycoprotein inhibitor. In addition, the mixed micelle formulation showed a bimodal presentation, presumably attributed to enterohepatic recirculation, further enhancing the drug&#x02019;s oral bioavailability [<xref ref-type="bibr" rid="CR94">94</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Baicalin blood levels after oral administration of baicalin (BC) and BC-loaded ST-P123-MMs (P123, an amphipathic polymer and sodium taurocholate as a carrier); upper right: drug release of baicalin. Reproduced from [<xref ref-type="bibr" rid="CR94">94</xref>] with permission</p></caption><graphic xlink:href="13346_2019_691_Fig3_HTML" id="MO4"/></fig></p><p id="Par14">Oleanolic acid has low aqueous solubility and systemic bioavailability (0.7% in rats). SMEDDS was developed in an attempt to overcome these limitations. This delivery system consisted of 50% ethyl oleate (oil), 35% Cremophor EL (surfactant), and 15% alcohol (co-surfactant), allowing a great increase in oleanolic acid solubility [<xref ref-type="bibr" rid="CR151">151</xref>]. <italic>In vitro</italic> studies showed a sustained release behavior from SMEDDS. Systemic rat bioavailability was significantly higher in SMEDDS than in the marketed tablets of oleanolic acid (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The improved drug&#x02019;s oral bioavailability was explained by enhanced solubility and permeability through emulsification and small particle sizes, respectively.<fig id="Fig4"><label>Fig. 4</label><caption><p>Oleanolic acid rat blood levels after oral administration of oleanolic acid-loaded SMEDDS (filled diamonds) and marketed drug product (tablet) (filled squares); upper right: accumulative release of oleanolic acid. Reproduced from [<xref ref-type="bibr" rid="CR151">151</xref>] with permission</p></caption><graphic xlink:href="13346_2019_691_Fig4_HTML" id="MO5"/></fig></p><p id="Par15"><italic>Flos Lonicerae Japonicae</italic> and <italic>Fructus forsythia</italic> are used together in Chinese herbal remedies, and both have antiviral, antibacterial, and antiinflammatory properties. An attempt was made to enhance the bioavailability and antiinfluenza properties of the herb combination by chito-oligosaccharide, a chitosan derivative [<xref ref-type="bibr" rid="CR122">122</xref>]. In a cell culture antiinfluenza assay, chito-oligosaccharide improved the activity of extracts containing <italic>Flos Lonicerae Japonicae</italic> and <italic>Fructus forsythia</italic>, compared to extracts that do not contain the chito-oligosaccharide. The absorption was studied <italic>in vitro</italic> using Caco-2 model, and higher experimentally derived apparent permeability values were obtained with increasing concentrations of chito-oligosaccharide. <italic>In vivo</italic> pharmacokinetics showed a significant increase in <italic>Flos Lonicerae Japonicae</italic> and <italic>Fructus forsythia</italic> concentrations when co-delivered with chito-oligosaccharide, relative to herb administration alone (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). In addition, enhanced antiviral effect was achieved in four preparations containing chito-oligosaccharide, which was explained by the higher absorption of caffeic acid derivatives (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). This work was unique because it studied the effects of the delivery system on both the pharmacokinetic properties and the antiviral activity of the herbal drug, directly.<fig id="Fig5"><label>Fig. 5</label><caption><p>Effect of COS (chito-oligosaccharide) on the pharmacokinetic (panel <bold>a</bold>) and pharmacodynamics (inhibition of influenza virus; panel <bold>b</bold>) of caffeic acid derivative after oral administration of preparation containing <italic>Flos Lonicerae Japonicae</italic> and Fructus, forsythia extracts. Black, 1:1:2-fold of <italic>Flos Lonicerae Japonicae</italic>, Fructus Forsythiae, and Radix Scutellariae, respectively; red, only Radix Scutellariae; green, 2:2:2-fold of <italic>Flos Lonicerae Japonicae</italic>, Fructus Forsythiae, and Radix Scutellariae, respectively; yellow, COS with added Radix Scutellariae only; blue, COS with added 1:1:2-fold of <italic>Flos Lonicerae Japonicae</italic>, Fructus Forsythiae, and Radix Scutellariae, respectively (<italic>n</italic> = 6). Reproduced from [<xref ref-type="bibr" rid="CR122">122</xref>] with permission</p></caption><graphic xlink:href="13346_2019_691_Fig5_HTML" id="MO6"/></fig></p><p id="Par16">An inclusion complex of honokiol and sulfobutyl ether-&#x003b2;-cyclodextrin was made to enhance the solubility and bioavailability of the herbal drug [<xref ref-type="bibr" rid="CR148">148</xref>]. In a phase solubility experiment, honokiol solubility linearly increased with growing levels of the cyclodextrin. The <italic>in vitro</italic> release study showed that the honokiol/cyclodextrin complex allowed enhanced release rate than either honokiol/cyclodextrin physical mixture or honokiol alone. In rat oral pharmacokinetics, AUC and <italic>C</italic><sub>max</sub> values of the inclusion complex were 1.58 and 1.23 times higher relative to honokiol suspension, respectively. Also, honokiol in suspension had 3 times higher body clearance than complexed honokiol.</p><p id="Par17">Andrographolide is sparingly soluble in water, unstable in very acidic and basic conditions, poorly absorbed, and has low oral bioavailability. PLGA (poly(lactic-co-glycolic acid)) was used to form andrographolide loaded microspheres to overcome these limitations [<xref ref-type="bibr" rid="CR124">124</xref>]. <italic>In vitro</italic> andrographolide-microsphere formulation exhibited sustained release profile over 9 days, with just 14% andrographolide release over the first 8 h, because of low drug density at the surface of the delivery system, which also allowed a relatively high oral bioavailability of 67.5%. Lastly, fine correlation was obtained between <italic>in vitro</italic> drug release and <italic>in vivo</italic> absorption, indicating that the <italic>in vitro</italic> assay may be a good predictor of drug absorption <italic>in vivo</italic>.</p><p id="Par18">Curcumin, a polyphenolic compound with various medical applications including known antivirus activity, is poorly water-soluble and has low oral bioavailability. With N-acetyl L-cysteine and different levels (20, 50, and 100 mg) of polyethylene glycol (PEG), nanostructured solid lipid carriers were synthesized to obtain curcumin mucoadhesion and mucus penetration [<xref ref-type="bibr" rid="CR156">156</xref>]. Drug release was characterized <italic>in vitro</italic> for curcumin solution, curcumin-loaded nanolipid carrier, and curcumin-loaded nanolipid carrier with N-acetyl L-cysteine PEG. From the curcumin solution, 80% of drug was released after 4 h, whereas all the nanolipid formulations allowed sustained curcumin release; the sustained release effect from the modified nanolipid carriers was more pronounced than that of unmodified nanolipids. An SPIP study in rats was then conducted, and results were similar for all three parts of the small intestine: nanolipids allowed enhanced curcumin permeation relative to solution, and so did higher N-acetyl L-cysteine content. Pharmacokinetic study of curcumin solutions (P.O and I.V) and curcumin nanolipid carriers (with N-acetyl L-cysteine PEG content of 0, 20, 50, and 100 mg) was conducted. Similar to the results of the permeability experiment, plasma curcumin concentrations were higher with nanolipid carriers relative to solution (either P.O or I.V) and increased further with higher N-acetyl L-cysteine PEG levels. The area under the curve was substantially larger with the modified nanolipid carriers compared to either curcumin solution or to the unmodified delivery system.</p><p id="Par19">Indeed, modern drug delivery technologies are numerous, and tailoring the most appropriate formulation to the medicinal phytochemical in question is not just a matter of trial and error; rather, the physicochemical properties of the specific natural drug substance determine the delivery issues that the formulator may face, and the excipients that can be used to overcome these challenges [<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR158">158</xref>]. Among the physicochemical properties of importance are log P (a measure of the drug&#x02019;s lipophilicity) and melting point. These parameters will determine the likelihood of the active substance to precipitate in the gastrointestinal lumen, in which case the use of amorphous formulations may be preferred over other oral carriers. Additional important physicochemical properties include the drug&#x02019;s chemical structure and molecular weight; using previously successful formulations to deliver drugs with similar chemical structure may be a wise approach. Also, generally speaking, higher molecular weight substances may be better incorporated into lipid-based drug delivery systems [<xref ref-type="bibr" rid="CR159">159</xref>&#x02013;<xref ref-type="bibr" rid="CR161">161</xref>]. It should be noted that some solubility-enabling formulations may simultaneously decrease the drug&#x02019;s permeability, and overall absorption may be unimproved. This solubility-permeability interplay was shown for formulations based on cyclodextrins [<xref ref-type="bibr" rid="CR162">162</xref>&#x02013;<xref ref-type="bibr" rid="CR164">164</xref>], surfactants [<xref ref-type="bibr" rid="CR165">165</xref>], cosolvents [<xref ref-type="bibr" rid="CR166">166</xref>], and hydrotropes [<xref ref-type="bibr" rid="CR167">167</xref>, <xref ref-type="bibr" rid="CR168">168</xref>]. In amorphous solid dispersions (ASD), on the other hand, the solubility increases (via supersaturation) with unchanged permeability, and thus, ASD may be preferred over other carrier systems, given supersaturation can be achieved and maintained for sufficient time [<xref ref-type="bibr" rid="CR169">169</xref>].</p></sec><sec id="Sec4"><title>Conclusions</title><p id="Par20">Altogether, the evidence presented in this work supports the notion that medicinal plants have promising therapeutic potential, especially in the case of herb products against viral infections. Further research on the mechanisms by which phytochemicals exhibit their antiviral effect will allow the developing of successful target-specific drug delivery systems. At the moment, we cannot ensure the plant phytochemicals directly reach viruses or the correct structures inside cells. Ideally, we would have smart pharmaceutical nanotechnologies and targeting strategies that can avoid cellular defenses, transport drugs to targeted intracellular sites, and release the drugs in response to specific molecular signals. Literature also lacks randomized clinical trials to discern the strength of new herbal antiviral drug delivery systems. It is our hope that in the future more high quality clinically relevant studies will accumulate in the literature, which will shed light on the full potential of phytochemicals as novel antiviral agents in adequate delivery systems.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes notes-type="COI-statement"><title>Conflict of interest</title><p id="Par21">The authors declare that they have no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasparini</surname><given-names>R</given-names></name><name><surname>Amicizia</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>PL</given-names></name><name><surname>Panatto</surname><given-names>D</given-names></name></person-group><article-title>Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly</article-title><source>Hum Vaccin Immunother</source><year>2012</year><volume>8</volume><issue>1</issue><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.4161/hv.8.1.17622</pub-id><?supplied-pmid 22252007?><pub-id pub-id-type="pmid">22252007</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novakova</surname><given-names>L</given-names></name><name><surname>Pavlik</surname><given-names>J</given-names></name><name><surname>Chrenkova</surname><given-names>L</given-names></name><name><surname>Martinec</surname><given-names>O</given-names></name><name><surname>Cerveny</surname><given-names>L</given-names></name></person-group><article-title>Current antiviral drugs and their analysis in biological materials &#x02013; part II: antivirals against hepatitis and HIV viruses</article-title><source>J Pharm Biomed Anal</source><year>2018</year><volume>147</volume><fpage>378</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2017.07.003</pub-id><?supplied-pmid 29031512?><pub-id pub-id-type="pmid">29031512</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltan</surname><given-names>MM</given-names></name><name><surname>Zaki</surname><given-names>AK</given-names></name></person-group><article-title>Antiviral screening of forty-two Egyptian medicinal plants</article-title><source>J Ethnopharmacol</source><year>2009</year><volume>126</volume><issue>1</issue><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.08.001</pub-id><?supplied-pmid 19666102?><pub-id pub-id-type="pmid">19666102</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brijesh</surname><given-names>S</given-names></name><name><surname>Daswani</surname><given-names>P</given-names></name><name><surname>Tetali</surname><given-names>P</given-names></name><name><surname>Antia</surname><given-names>N</given-names></name><name><surname>Birdi</surname><given-names>T</given-names></name></person-group><article-title>Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage</article-title><source>BMC Complement Altern Med</source><year>2009</year><volume>9</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-9-47</pub-id><?supplied-pmid 19930633?><pub-id pub-id-type="pmid">19930633</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>MT</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M</given-names></name><name><surname>Karimi</surname><given-names>A</given-names></name></person-group><article-title>A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus</article-title><source>Avicenna J Phytomed</source><year>2016</year><volume>6</volume><issue>5</issue><fpage>506</fpage><lpage>515</lpage><?supplied-pmid 27761420?><pub-id pub-id-type="pmid">27761420</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>JL</given-names></name><name><surname>Lopes</surname><given-names>RC</given-names></name><name><surname>Oliveira</surname><given-names>DB</given-names></name><name><surname>Costa</surname><given-names>SS</given-names></name><name><surname>Miranda</surname><given-names>MM</given-names></name><name><surname>Romanos</surname><given-names>MT</given-names></name><name><surname>Santos</surname><given-names>NS</given-names></name><name><surname>Wigg</surname><given-names>MD</given-names></name></person-group><article-title>In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>99</volume><issue>3</issue><fpage>403</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.01.032</pub-id><?supplied-pmid 15876501?><pub-id pub-id-type="pmid">15876501</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maregesi</surname><given-names>SM</given-names></name><name><surname>Pieters</surname><given-names>L</given-names></name><name><surname>Ngassapa</surname><given-names>OD</given-names></name><name><surname>Apers</surname><given-names>S</given-names></name><name><surname>Vingerhoets</surname><given-names>R</given-names></name><name><surname>Cos</surname><given-names>P</given-names></name><name><surname>Berghe</surname><given-names>DA</given-names></name><name><surname>Vlietinck</surname><given-names>AJ</given-names></name></person-group><article-title>Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities</article-title><source>J Ethnopharmacol</source><year>2008</year><volume>119</volume><issue>1</issue><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.05.033</pub-id><?supplied-pmid 18582554?><pub-id pub-id-type="pmid">18582554</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamese</surname><given-names>M</given-names></name><name><surname>Aydogdu</surname><given-names>S</given-names></name><name><surname>Karamese</surname><given-names>SA</given-names></name><name><surname>Altoparlak</surname><given-names>U</given-names></name><name><surname>Gundogdu</surname><given-names>C</given-names></name></person-group><article-title>Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication</article-title><source>Asian Pac J Cancer Prev</source><year>2015</year><volume>16</volume><issue>10</issue><fpage>4199</fpage><lpage>4202</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2015.16.10.4199</pub-id><pub-id pub-id-type="pmid">26028072</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><issue>5</issue><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.09.006</pub-id><?supplied-pmid 19019643?><pub-id pub-id-type="pmid">19019643</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callies</surname><given-names>O</given-names></name><name><surname>Bedoya</surname><given-names>LM</given-names></name><name><surname>Beltran</surname><given-names>M</given-names></name><name><surname>Munoz</surname><given-names>A</given-names></name><name><surname>Calderon</surname><given-names>PO</given-names></name><name><surname>Osorio</surname><given-names>AA</given-names></name><name><surname>Jimenez</surname><given-names>IA</given-names></name><name><surname>Alcami</surname><given-names>J</given-names></name><name><surname>Bazzocchi</surname><given-names>IL</given-names></name></person-group><article-title>Isolation, structural modification, and HIV inhibition of pentacyclic lupane-type triterpenoids from Cassine xylocarpa and Maytenus cuzcoina</article-title><source>J Nat Prod</source><year>2015</year><volume>78</volume><issue>5</issue><fpage>1045</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1021/np501025r</pub-id><?supplied-pmid 25927586?><pub-id pub-id-type="pmid">25927586</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droebner</surname><given-names>K</given-names></name><name><surname>Ehrhardt</surname><given-names>C</given-names></name><name><surname>Poetter</surname><given-names>A</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name><name><surname>Planz</surname><given-names>O</given-names></name></person-group><article-title>CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice</article-title><source>Antiviral Res</source><year>2007</year><volume>76</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2007.04.001</pub-id><?supplied-pmid 17573133?><pub-id pub-id-type="pmid">17573133</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname><given-names>C</given-names></name><name><surname>Hrincius</surname><given-names>ER</given-names></name><name><surname>Korte</surname><given-names>V</given-names></name><name><surname>Mazur</surname><given-names>I</given-names></name><name><surname>Droebner</surname><given-names>K</given-names></name><name><surname>Poetter</surname><given-names>A</given-names></name><name><surname>Dreschers</surname><given-names>S</given-names></name><name><surname>Schmolke</surname><given-names>M</given-names></name><name><surname>Planz</surname><given-names>O</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name></person-group><article-title>A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance</article-title><source>Antiviral Res</source><year>2007</year><volume>76</volume><issue>1</issue><fpage>38</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2007.05.002</pub-id><?supplied-pmid 17572513?><pub-id pub-id-type="pmid">17572513</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebensburg</surname><given-names>S</given-names></name><name><surname>Helfer</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Koppensteiner</surname><given-names>H</given-names></name><name><surname>Eberle</surname><given-names>J</given-names></name><name><surname>Schindler</surname><given-names>M</given-names></name><name><surname>Gurtler</surname><given-names>L</given-names></name><name><surname>Brack-Werner</surname><given-names>R</given-names></name></person-group><article-title>Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>20394</fpage><pub-id pub-id-type="doi">10.1038/srep20394</pub-id><?supplied-pmid 26833261?><pub-id pub-id-type="pmid">26833261</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>HB</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name><name><surname>Geng</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>XL</given-names></name><name><surname>Yang</surname><given-names>CY</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: rhizomes of Cyperus rotundus</article-title><source>J Ethnopharmacol</source><year>2015</year><volume>171</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.05.040</pub-id><?supplied-pmid 26051832?><pub-id pub-id-type="pmid">26051832</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>V</given-names></name><name><surname>Potterat</surname><given-names>O</given-names></name><name><surname>Louvel</surname><given-names>S</given-names></name><name><surname>Hamy</surname><given-names>F</given-names></name><name><surname>Mojarrab</surname><given-names>M</given-names></name><name><surname>Sanglier</surname><given-names>JJ</given-names></name><name><surname>Klimkait</surname><given-names>T</given-names></name><name><surname>Hamburger</surname><given-names>M</given-names></name></person-group><article-title>Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium</article-title><source>J Nat Prod</source><year>2012</year><volume>75</volume><issue>3</issue><fpage>414</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1021/np200855d</pub-id><?supplied-pmid 22148316?><pub-id pub-id-type="pmid">22148316</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abad</surname><given-names>MJ</given-names></name><name><surname>Guerra</surname><given-names>JA</given-names></name><name><surname>Bermejo</surname><given-names>P</given-names></name><name><surname>Irurzun</surname><given-names>A</given-names></name><name><surname>Carrasco</surname><given-names>L</given-names></name></person-group><article-title>Search for antiviral activity in higher plant extracts</article-title><source>Phytother Res</source><year>2000</year><volume>14</volume><issue>8</issue><fpage>604</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1002/1099-1573(200012)14:8&#x0003c;604::AID-PTR678&#x0003e;3.0.CO;2-L</pub-id><pub-id pub-id-type="pmid">11113996</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyuris</surname><given-names>A</given-names></name><name><surname>Szlavik</surname><given-names>L</given-names></name><name><surname>Minarovits</surname><given-names>J</given-names></name><name><surname>Vasas</surname><given-names>A</given-names></name><name><surname>Molnar</surname><given-names>J</given-names></name><name><surname>Hohmann</surname><given-names>J</given-names></name></person-group><article-title>Antiviral activities of extracts of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251</article-title><source>In Vivo</source><year>2009</year><volume>23</volume><issue>3</issue><fpage>429</fpage><lpage>432</lpage><?supplied-pmid 19454510?><pub-id pub-id-type="pmid">19454510</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarmolinsky</surname><given-names>L</given-names></name><name><surname>Huleihel</surname><given-names>M</given-names></name><name><surname>Zaccai</surname><given-names>M</given-names></name><name><surname>Ben-Shabat</surname><given-names>S</given-names></name></person-group><article-title>Potent antiviral flavone glycosides from Ficus benjamina leaves</article-title><source>Fitoterapia</source><year>2012</year><volume>83</volume><issue>2</issue><fpage>362</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2011.11.014</pub-id><?supplied-pmid 22155188?><pub-id pub-id-type="pmid">22155188</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><article-title>Studies on anti-HSV effect of Ficus carica leaves</article-title><source>Zhong Yao Cai</source><year>2004</year><volume>27</volume><issue>10</issue><fpage>754</fpage><lpage>756</lpage><?supplied-pmid 15850358?><pub-id pub-id-type="pmid">15850358</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazreg Aref</surname><given-names>H</given-names></name><name><surname>Gaaliche</surname><given-names>B</given-names></name><name><surname>Fekih</surname><given-names>A</given-names></name><name><surname>Mars</surname><given-names>M</given-names></name><name><surname>Aouni</surname><given-names>M</given-names></name><name><surname>Pierre Chaumon</surname><given-names>J</given-names></name><name><surname>Said</surname><given-names>K</given-names></name></person-group><article-title>In vitro cytotoxic and antiviral activities of Ficus carica latex extracts</article-title><source>Nat Prod Res</source><year>2011</year><volume>25</volume><issue>3</issue><fpage>310</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1080/14786419.2010.528758</pub-id><?supplied-pmid 21294043?><pub-id pub-id-type="pmid">21294043</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asl Najjari</surname><given-names>AH</given-names></name><name><surname>Rajabi</surname><given-names>Z</given-names></name><name><surname>Vasfi Marandi</surname><given-names>M</given-names></name><name><surname>Dehghan</surname><given-names>G</given-names></name></person-group><article-title>The effect of the hexanic extracts of fig (Ficus carica) and olive (Olea europaea) fruit and nanoparticles of selenium on the immunogenicity of the inactivated avian influenza virus subtype H9N2</article-title><source>Vet Res Forum</source><year>2015</year><volume>6</volume><issue>3</issue><fpage>227</fpage><lpage>231</lpage><?supplied-pmid 26893813?><pub-id pub-id-type="pmid">26893813</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>A</given-names></name><name><surname>Ashraf</surname><given-names>MM</given-names></name><name><surname>Rafiqe</surname><given-names>A</given-names></name><name><surname>Aslam</surname><given-names>B</given-names></name><name><surname>Galani</surname><given-names>S</given-names></name><name><surname>Zafar</surname><given-names>S</given-names></name><name><surname>Asad</surname><given-names>F</given-names></name><name><surname>Asghar</surname><given-names>RD</given-names></name><name><surname>Akram</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>H</given-names></name><name><surname>Shah</surname><given-names>SMA</given-names></name><name><surname>Asif</surname><given-names>R</given-names></name></person-group><article-title>In vivo antiviral potential of Glycyrrhiza glabra extract against Newcastle disease virus</article-title><source>Pak J Pharm Sci</source><year>2017</year><volume>30</volume><issue>2 Suppl</issue><fpage>567</fpage><lpage>572</lpage><?supplied-pmid 28650322?><pub-id pub-id-type="pmid">28650322</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfajaro</surname><given-names>MM</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>JG</given-names></name><name><surname>Ryu</surname><given-names>EH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Jeong</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Hosmillo</surname><given-names>M</given-names></name><name><surname>Son</surname><given-names>KY</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>HJ</given-names></name><name><surname>Ryu</surname><given-names>YB</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SI</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Cho</surname><given-names>KO</given-names></name></person-group><article-title>Anti-rotaviral effects of Glycyrrhiza uralensis extract in piglets with rotavirus diarrhea</article-title><source>Virol J</source><year>2012</year><volume>9</volume><fpage>310</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-9-310</pub-id><?supplied-pmid 23244491?><pub-id pub-id-type="pmid">23244491</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szlavik</surname><given-names>L</given-names></name><name><surname>Gyuris</surname><given-names>A</given-names></name><name><surname>Minarovits</surname><given-names>J</given-names></name><name><surname>Forgo</surname><given-names>P</given-names></name><name><surname>Molnar</surname><given-names>J</given-names></name><name><surname>Hohmann</surname><given-names>J</given-names></name></person-group><article-title>Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids</article-title><source>Planta Med</source><year>2004</year><volume>70</volume><issue>9</issue><fpage>871</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1055/s-2004-827239</pub-id><?supplied-pmid 15386196?><pub-id pub-id-type="pmid">15386196</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarmolinsky</surname><given-names>L</given-names></name><name><surname>Zaccai</surname><given-names>M</given-names></name><name><surname>Ben-Shabat</surname><given-names>S</given-names></name><name><surname>Mills</surname><given-names>D</given-names></name><name><surname>Huleihel</surname><given-names>M</given-names></name></person-group><article-title>Antiviral activity of ethanol extracts of Ficus binjamina and Lilium candidum in vitro</article-title><source>N Biotechnol</source><year>2009</year><volume>26</volume><issue>6</issue><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.nbt.2009.08.005</pub-id><?supplied-pmid 19703599?><pub-id pub-id-type="pmid">19703599</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Wu</surname><given-names>HN</given-names></name><name><surname>Ping</surname><given-names>YH</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Shiuan</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><name><surname>Lee</surname><given-names>YR</given-names></name><name><surname>Huang</surname><given-names>KJ</given-names></name></person-group><article-title>Honokiol, a lignan biphenol derived from the Magnolia Tree, inhibits dengue virus type 2 infection</article-title><source>Viruses</source><year>2015</year><volume>7</volume><issue>9</issue><fpage>4894</fpage><lpage>4910</lpage><pub-id pub-id-type="doi">10.3390/v7092852</pub-id><?supplied-pmid 26378567?><pub-id pub-id-type="pmid">26378567</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astani</surname><given-names>A</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Schnitzler</surname><given-names>P</given-names></name></person-group><article-title>Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro</article-title><source>Chemotherapy</source><year>2012</year><volume>58</volume><issue>1</issue><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1159/000335590</pub-id><?supplied-pmid 22377592?><pub-id pub-id-type="pmid">22377592</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolkemper</surname><given-names>S</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Stintzing</surname><given-names>FC</given-names></name><name><surname>Carle</surname><given-names>R</given-names></name><name><surname>Schnitzler</surname><given-names>P</given-names></name></person-group><article-title>Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro</article-title><source>Planta Med</source><year>2006</year><volume>72</volume><issue>15</issue><fpage>1378</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1055/s-2006-951719</pub-id><?supplied-pmid 17091431?><pub-id pub-id-type="pmid">17091431</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geuenich</surname><given-names>S</given-names></name><name><surname>Goffinet</surname><given-names>C</given-names></name><name><surname>Venzke</surname><given-names>S</given-names></name><name><surname>Nolkemper</surname><given-names>S</given-names></name><name><surname>Baumann</surname><given-names>I</given-names></name><name><surname>Plinkert</surname><given-names>P</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Keppler</surname><given-names>OT</given-names></name></person-group><article-title>Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density</article-title><source>Retrovirology</source><year>2008</year><volume>5</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-5-27</pub-id><?supplied-pmid 18355409?><pub-id pub-id-type="pmid">18355409</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsania</surname><given-names>M</given-names></name><name><surname>Rezaee</surname><given-names>MB</given-names></name><name><surname>Monavari</surname><given-names>SH</given-names></name><name><surname>Jaimand</surname><given-names>K</given-names></name><name><surname>Mousavi-Jazayeri</surname><given-names>SM</given-names></name><name><surname>Razazian</surname><given-names>M</given-names></name><name><surname>Nadjarha</surname><given-names>MH</given-names></name></person-group><article-title>Antiviral screening of four plant extracts against acyclovir resistant herpes simplex virus type-1</article-title><source>Pak J Pharm Sci</source><year>2017</year><volume>30</volume><issue>4 Suppl</issue><fpage>1407</fpage><lpage>1411</lpage><?supplied-pmid 29043989?><pub-id pub-id-type="pmid">29043989</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JG</given-names></name><name><surname>Jin</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Oh</surname><given-names>TW</given-names></name><name><surname>Yim</surname><given-names>NH</given-names></name><name><surname>Cho</surname><given-names>WK</given-names></name><name><surname>Ma</surname><given-names>JY</given-names></name></person-group><article-title>Protective effect of Panax notoginseng root water extract against influenza A virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>1542</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.01542</pub-id><?supplied-pmid 29181006?><pub-id pub-id-type="pmid">29181006</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>HT</given-names></name><name><surname>Cheng</surname><given-names>RR</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name></person-group><article-title>Anti-hepatitis B virus norbisabolane sesquiterpenoids from Phyllanthus acidus and the establishment of their absolute configurations using theoretical calculations</article-title><source>J Org Chem</source><year>2014</year><volume>79</volume><issue>12</issue><fpage>5432</fpage><lpage>5447</lpage><pub-id pub-id-type="doi">10.1021/jo5004604</pub-id><?supplied-pmid 24824117?><pub-id pub-id-type="pmid">24824117</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Xin</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>RR</given-names></name><name><surname>Zhu</surname><given-names>HT</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name></person-group><article-title>Anti-viral and cytotoxic norbisabolane sesquiterpenoid glycosides from Phyllanthus emblica and their absolute configurations</article-title><source>Phytochemistry</source><year>2015</year><volume>117</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2015.06.001</pub-id><?supplied-pmid 26074492?><pub-id pub-id-type="pmid">26074492</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>JJ</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Zhang</surname><given-names>JM</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>HT</given-names></name><name><surname>Cheng</surname><given-names>RR</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name></person-group><article-title>Anti-hepatitis B virus activities and absolute configurations of sesquiterpenoid glycosides from Phyllanthus emblica</article-title><source>Org Biomol Chem</source><year>2014</year><volume>12</volume><issue>43</issue><fpage>8764</fpage><lpage>8774</lpage><pub-id pub-id-type="doi">10.1039/c4ob01196a</pub-id><?supplied-pmid 25268491?><pub-id pub-id-type="pmid">25268491</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Brindley</surname><given-names>MA</given-names></name><name><surname>Widrlechner</surname><given-names>MP</given-names></name><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>McCoy</surname><given-names>JA</given-names></name><name><surname>Murphy</surname><given-names>P</given-names></name><name><surname>Hauck</surname><given-names>C</given-names></name><name><surname>Maury</surname><given-names>W</given-names></name></person-group><article-title>Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>188</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-188</pub-id><?supplied-pmid 21513560?><pub-id pub-id-type="pmid">21513560</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ao</surname><given-names>Z</given-names></name><name><surname>Bello</surname><given-names>A</given-names></name><name><surname>Ran</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wigle</surname><given-names>J</given-names></name><name><surname>Kobinger</surname><given-names>G</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name></person-group><article-title>Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection</article-title><source>Antiviral Res</source><year>2016</year><volume>127</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.01.001</pub-id><?supplied-pmid 26778707?><pub-id pub-id-type="pmid">26778707</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>A</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M</given-names></name><name><surname>Moradi</surname><given-names>MT</given-names></name><name><surname>Alidadi</surname><given-names>S</given-names></name></person-group><article-title>Anti-herpes simplex virus type-1 activity and phenolic content of crude ethanol extract and four corresponding fractions of Quercus brantii L Acorn</article-title><source>J Evid Based Complementary Altern Med</source><year>2016</year><volume>22</volume><issue>3</issue><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1177/2156587216676421</pub-id><?supplied-pmid 27899436?><pub-id pub-id-type="pmid">27899436</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>A</given-names></name><name><surname>Moradi</surname><given-names>MT</given-names></name><name><surname>Saeedi</surname><given-names>M</given-names></name><name><surname>Asgari</surname><given-names>S</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M</given-names></name></person-group><article-title>Antiviral activity of Quercus persica L.: high efficacy and low toxicity</article-title><source>Adv Biomed Res</source><year>2013</year><volume>2</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.4103/2277-9175.109722</pub-id><?supplied-pmid 24516836?><pub-id pub-id-type="pmid">24516836</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Perez</surname><given-names>GA</given-names></name><name><surname>Egashira</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>Y</given-names></name><name><surname>Tsuruta</surname><given-names>T</given-names></name><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Ueda</surname><given-names>F</given-names></name><name><surname>Tsukahara</surname><given-names>T</given-names></name><name><surname>Tsukamoto</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>R</given-names></name></person-group><article-title>Orally administered Salacia reticulata extract reduces H1N1 influenza clinical symptoms in murine lung tissues putatively due to enhanced natural killer cell activity</article-title><source>Front Immunol</source><year>2016</year><volume>7</volume><fpage>115</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00115</pub-id><?supplied-pmid 27066007?><pub-id pub-id-type="pmid">27066007</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedoya</surname><given-names>LM</given-names></name><name><surname>Sanchez-Palomino</surname><given-names>S</given-names></name><name><surname>Abad</surname><given-names>MJ</given-names></name><name><surname>Bermejo</surname><given-names>P</given-names></name><name><surname>Alcami</surname><given-names>J</given-names></name></person-group><article-title>Anti-HIV activity of medicinal plant extracts</article-title><source>J Ethnopharmacol</source><year>2001</year><volume>77</volume><issue>1</issue><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00265-3</pub-id><pub-id pub-id-type="pmid">11483387</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>T</given-names></name><name><surname>Ashfaq</surname><given-names>UA</given-names></name><name><surname>Riaz</surname><given-names>S</given-names></name><name><surname>Rehman</surname><given-names>S</given-names></name><name><surname>Riazuddin</surname><given-names>S</given-names></name></person-group><article-title>In-vitro antiviral activity of Solanum nigrum against hepatitis C virus</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-26</pub-id><?supplied-pmid 21247464?><pub-id pub-id-type="pmid">21247464</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>S</given-names></name><name><surname>Ijaz</surname><given-names>B</given-names></name><name><surname>Fatima</surname><given-names>N</given-names></name><name><surname>Muhammad</surname><given-names>SA</given-names></name><name><surname>Riazuddin</surname><given-names>S</given-names></name></person-group><article-title>Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: in-vitro and In silico study</article-title><source>Biomed Pharmacother</source><year>2016</year><volume>83</volume><fpage>881</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.08.002</pub-id><?supplied-pmid 27513212?><pub-id pub-id-type="pmid">27513212</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>B</given-names></name></person-group><article-title>Anti-influenza virus effect of aqueous extracts from dandelion</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>538</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-538</pub-id><?supplied-pmid 22168277?><pub-id pub-id-type="pmid">22168277</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimani Farsani</surname><given-names>M</given-names></name><name><surname>Behbahani</surname><given-names>M</given-names></name><name><surname>Isfahani</surname><given-names>HZ</given-names></name></person-group><article-title>The effect of root, shoot and seed extracts of the Iranian Thymus L. (Family: Lamiaceae) species on HIV-1 replication and CD4 expression</article-title><source>Cell J</source><year>2016</year><volume>18</volume><issue>2</issue><fpage>255</fpage><lpage>261</lpage><?supplied-pmid 27540531?><pub-id pub-id-type="pmid">27540531</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedoya</surname><given-names>LM</given-names></name><name><surname>Abad</surname><given-names>MJ</given-names></name><name><surname>Sanchez-Palomino</surname><given-names>S</given-names></name><name><surname>Alcami</surname><given-names>J</given-names></name><name><surname>Bermejo</surname><given-names>P</given-names></name></person-group><article-title>Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><issue>1</issue><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.08.008</pub-id><?supplied-pmid 19748255?><pub-id pub-id-type="pmid">19748255</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>JJ</given-names></name><name><surname>Tao</surname><given-names>HM</given-names></name><name><surname>Min</surname><given-names>QX</given-names></name><name><surname>Zhu</surname><given-names>QH</given-names></name></person-group><article-title>Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging</article-title><source>Phytomedicine</source><year>2015</year><volume>22</volume><issue>7-8</issue><fpage>724</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2015.05.001</pub-id><?supplied-pmid 26141758?><pub-id pub-id-type="pmid">26141758</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabzadeh</surname><given-names>AM</given-names></name><name><surname>Ansari-Dogaheh</surname><given-names>M</given-names></name><name><surname>Sharififar</surname><given-names>F</given-names></name><name><surname>Shakibaie</surname><given-names>M</given-names></name><name><surname>Heidarbeigi</surname><given-names>M</given-names></name></person-group><article-title>Anti herpes simplex-1 activity of a standard extract of Zataria multiflora Boiss</article-title><source>Pak J Biol Sci</source><year>2013</year><volume>16</volume><issue>4</issue><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.3923/pjbs.2013.180.184</pub-id><pub-id pub-id-type="pmid">24171266</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>AK</given-names></name><name><surname>Youssef</surname><given-names>AI</given-names></name><name><surname>Arafa</surname><given-names>AS</given-names></name><name><surname>Ahmed</surname><given-names>SA</given-names></name></person-group><article-title>Anti-H5N1 virus flavonoids from Capparis sinaica Veill</article-title><source>Nat Prod Res</source><year>2013</year><volume>27</volume><issue>22</issue><fpage>2149</fpage><lpage>2153</lpage><pub-id pub-id-type="doi">10.1080/14786419.2013.790027</pub-id><?supplied-pmid 23651316?><pub-id pub-id-type="pmid">23651316</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>DD</given-names></name><name><surname>Ozcelik</surname><given-names>B</given-names></name><name><surname>Ozgen</surname><given-names>S</given-names></name><name><surname>Ergun</surname><given-names>F</given-names></name></person-group><article-title>Antibacterial, antifungal, and antiviral activities of some flavonoids</article-title><source>Microbiol Res</source><year>2010</year><volume>165</volume><issue>6</issue><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.09.002</pub-id><?supplied-pmid 19840899?><pub-id pub-id-type="pmid">19840899</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry</article-title><source>Viruses</source><year>2015</year><volume>8</volume><issue>1</issue><fpage>E6</fpage><pub-id pub-id-type="doi">10.3390/v8010006</pub-id><?supplied-pmid 26712783?><pub-id pub-id-type="pmid">26712783</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>S</given-names></name><name><surname>Faris</surname><given-names>AN</given-names></name><name><surname>Comstock</surname><given-names>AT</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Nanua</surname><given-names>S</given-names></name><name><surname>Hershenson</surname><given-names>MB</given-names></name><name><surname>Sajjan</surname><given-names>US</given-names></name></person-group><article-title>Quercetin inhibits rhinovirus replication in vitro and in vivo</article-title><source>Antiviral Res</source><year>2012</year><volume>94</volume><issue>3</issue><fpage>258</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2012.03.005</pub-id><?supplied-pmid 22465313?><pub-id pub-id-type="pmid">22465313</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>K</given-names></name><name><surname>Teoh</surname><given-names>BT</given-names></name><name><surname>Sam</surname><given-names>SS</given-names></name><name><surname>Wong</surname><given-names>PF</given-names></name><name><surname>Mustafa</surname><given-names>MR</given-names></name><name><surname>Abubakar</surname><given-names>S</given-names></name></person-group><article-title>Antiviral activity of four types of bioflavonoid against dengue virus type-2</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>560</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-560</pub-id><?supplied-pmid 22201648?><pub-id pub-id-type="pmid">22201648</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>LC</given-names></name><name><surname>Chiang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>MC</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids</article-title><source>J Antimicrob Chemother</source><year>2003</year><volume>52</volume><issue>2</issue><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1093/jac/dkg291</pub-id><?supplied-pmid 12837746?><pub-id pub-id-type="pmid">12837746</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neznanov</surname><given-names>N</given-names></name><name><surname>Kondratova</surname><given-names>A</given-names></name><name><surname>Chumakov</surname><given-names>KM</given-names></name><name><surname>Neznanova</surname><given-names>L</given-names></name><name><surname>Kondratov</surname><given-names>R</given-names></name><name><surname>Banerjee</surname><given-names>AK</given-names></name><name><surname>Gudkov</surname><given-names>AV</given-names></name></person-group><article-title>Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin</article-title><source>DNA Cell Biol</source><year>2008</year><volume>27</volume><issue>4</issue><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1089/dna.2007.0682</pub-id><?supplied-pmid 18067462?><pub-id pub-id-type="pmid">18067462</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Son</surname><given-names>M</given-names></name><name><surname>Ryu</surname><given-names>E</given-names></name><name><surname>Shin</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Kang</surname><given-names>BW</given-names></name><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name></person-group><article-title>Quercetin-induced apoptosis prevents EBV infection</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><issue>14</issue><fpage>12603</fpage><lpage>12624</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.3687</pub-id><?supplied-pmid 26059439?><pub-id pub-id-type="pmid">26059439</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>dos Santos</surname><given-names>AE</given-names></name><name><surname>Kuster</surname><given-names>RM</given-names></name><name><surname>Yamamoto</surname><given-names>KA</given-names></name><name><surname>Salles</surname><given-names>TS</given-names></name><name><surname>Campos</surname><given-names>R</given-names></name><name><surname>de Meneses</surname><given-names>MD</given-names></name><name><surname>Soares</surname><given-names>MR</given-names></name><name><surname>Ferreira</surname><given-names>D</given-names></name></person-group><article-title>Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro virus activity</article-title><source>Parasit Vectors</source><year>2014</year><volume>7</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.1186/1756-3305-7-130</pub-id><?supplied-pmid 24678592?><pub-id pub-id-type="pmid">24678592</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johari</surname><given-names>J</given-names></name><name><surname>Kianmehr</surname><given-names>A</given-names></name><name><surname>Mustafa</surname><given-names>MR</given-names></name><name><surname>Abubakar</surname><given-names>S</given-names></name><name><surname>Zandi</surname><given-names>K</given-names></name></person-group><article-title>Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus</article-title><source>Int J Mol Sci</source><year>2012</year><volume>13</volume><issue>12</issue><fpage>16785</fpage><lpage>16795</lpage><pub-id pub-id-type="doi">10.3390/ijms131216785</pub-id><?supplied-pmid 23222683?><pub-id pub-id-type="pmid">23222683</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>KM</given-names></name><name><surname>Su</surname><given-names>MX</given-names></name><name><surname>Leung</surname><given-names>KT</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Zhang</surname><given-names>YW</given-names></name></person-group><article-title>Studies on antiviral constituents in stems and leaves of Pithecellibium clypearia</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2006</year><volume>31</volume><issue>5</issue><fpage>397</fpage><lpage>400</lpage><?supplied-pmid 16711425?><pub-id pub-id-type="pmid">16711425</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachmetov</surname><given-names>L</given-names></name><name><surname>Gal-Tanamy</surname><given-names>M</given-names></name><name><surname>Shapira</surname><given-names>A</given-names></name><name><surname>Vorobeychik</surname><given-names>M</given-names></name><name><surname>Giterman-Galam</surname><given-names>T</given-names></name><name><surname>Sathiyamoorthy</surname><given-names>P</given-names></name><name><surname>Golan-Goldhirsh</surname><given-names>A</given-names></name><name><surname>Benhar</surname><given-names>I</given-names></name><name><surname>Tur-Kaspa</surname><given-names>R</given-names></name><name><surname>Zemel</surname><given-names>R</given-names></name></person-group><article-title>Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity</article-title><source>J Viral Hepat</source><year>2012</year><volume>19</volume><issue>2</issue><fpage>e81</fpage><lpage>e88</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2893.2011.01507.x</pub-id><?supplied-pmid 22239530?><pub-id pub-id-type="pmid">22239530</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>O</given-names></name><name><surname>Fontanes</surname><given-names>V</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Loo</surname><given-names>R</given-names></name><name><surname>Loo</surname><given-names>J</given-names></name><name><surname>Arumugaswami</surname><given-names>V</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Dasgupta</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>SW</given-names></name></person-group><article-title>The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production</article-title><source>Hepatology</source><year>2009</year><volume>50</volume><issue>6</issue><fpage>1756</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1002/hep.23232</pub-id><?supplied-pmid 19839005?><pub-id pub-id-type="pmid">19839005</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakane</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name></person-group><article-title>Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases</article-title><source>Biochemistry</source><year>1990</year><volume>29</volume><issue>11</issue><fpage>2841</fpage><lpage>2845</lpage><pub-id pub-id-type="doi">10.1021/bi00463a029</pub-id><pub-id pub-id-type="pmid">1693287</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Hwang</surname><given-names>MW</given-names></name><name><surname>Bae</surname><given-names>JY</given-names></name><name><surname>Heo</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>SZ</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name></person-group><article-title>Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses</article-title><source>Biochem Biophys Res Commun</source><year>2013</year><volume>440</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.08.090</pub-id><?supplied-pmid 24012672?><pub-id pub-id-type="pmid">24012672</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Qiao</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>E</given-names></name></person-group><article-title>Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>10</issue><fpage>e110429</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0110429</pub-id><?supplied-pmid 25330384?><pub-id pub-id-type="pmid">25330384</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Qian</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity</article-title><source>Viruses</source><year>2015</year><volume>7</volume><issue>4</issue><fpage>1613</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.3390/v7041613</pub-id><?supplied-pmid 25835532?><pub-id pub-id-type="pmid">25835532</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>C</given-names></name><name><surname>Ohno</surname><given-names>M</given-names></name><name><surname>Otsuka</surname><given-names>M</given-names></name><name><surname>Kishikawa</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>K</given-names></name><name><surname>Muroyama</surname><given-names>R</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Takata</surname><given-names>A</given-names></name><name><surname>Koike</surname><given-names>K</given-names></name></person-group><article-title>The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels</article-title><source>Virology</source><year>2014</year><volume>462&#x02013;463</volume><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2014.05.024</pub-id><?supplied-pmid 25092460?><pub-id pub-id-type="pmid">25092460</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Avetisyan</surname><given-names>A</given-names></name><name><surname>Abroyan</surname><given-names>L</given-names></name><name><surname>Hakobyan</surname><given-names>L</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Apigenin inhibits African swine fever virus infection in vitro</article-title><source>Arch Virol</source><year>2016</year><volume>161</volume><issue>12</issue><fpage>3445</fpage><lpage>3453</lpage><pub-id pub-id-type="doi">10.1007/s00705-016-3061-y</pub-id><?supplied-pmid 27638776?><pub-id pub-id-type="pmid">27638776</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sithisarn</surname><given-names>P</given-names></name><name><surname>Michaelis</surname><given-names>M</given-names></name><name><surname>Schubert-Zsilavecz</surname><given-names>M</given-names></name><name><surname>Cinatl</surname><given-names>J</given-names><suffix>Jr</suffix></name></person-group><article-title>Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells</article-title><source>Antiviral Res</source><year>2013</year><volume>97</volume><issue>1</issue><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2012.10.004</pub-id><?supplied-pmid 23098745?><pub-id pub-id-type="pmid">23098745</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Xing</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>The antiviral effect of baicalin on enterovirus 71 in vitro</article-title><source>Viruses</source><year>2015</year><volume>7</volume><issue>8</issue><fpage>4756</fpage><lpage>4771</lpage><pub-id pub-id-type="doi">10.3390/v7082841</pub-id><?supplied-pmid 26295407?><pub-id pub-id-type="pmid">26295407</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghaddam</surname><given-names>E</given-names></name><name><surname>Teoh</surname><given-names>BT</given-names></name><name><surname>Sam</surname><given-names>SS</given-names></name><name><surname>Lani</surname><given-names>R</given-names></name><name><surname>Hassandarvish</surname><given-names>P</given-names></name><name><surname>Chik</surname><given-names>Z</given-names></name><name><surname>Yueh</surname><given-names>A</given-names></name><name><surname>Abubakar</surname><given-names>S</given-names></name><name><surname>Zandi</surname><given-names>K</given-names></name></person-group><article-title>Baicalin, a metabolite of baicalein with antiviral activity against dengue virus</article-title><source>Sci Rep</source><year>2014</year><volume>4</volume><fpage>5452</fpage><pub-id pub-id-type="doi">10.1038/srep05452</pub-id><?supplied-pmid 24965553?><pub-id pub-id-type="pmid">24965553</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Lv</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>RX</given-names></name><name><surname>Li</surname><given-names>E</given-names></name></person-group><article-title>Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>35851</fpage><pub-id pub-id-type="doi">10.1038/srep35851</pub-id><?supplied-pmid 27767097?><pub-id pub-id-type="pmid">27767097</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name></person-group><article-title>Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro</article-title><source>J Vet Med Sci</source><year>2016</year><volume>78</volume><issue>5</issue><fpage>819</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1292/jvms.15-0572</pub-id><?supplied-pmid 26902693?><pub-id pub-id-type="pmid">26902693</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Dongyan</surname><given-names>Y</given-names></name><name><surname>Mikovits</surname><given-names>JA</given-names></name><name><surname>Ruscetti</surname><given-names>FW</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name></person-group><article-title>Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>276</volume><issue>2</issue><fpage>534</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.3485</pub-id><?supplied-pmid 11027509?><pub-id pub-id-type="pmid">11027509</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name></person-group><article-title>Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs</article-title><source>Toxicol Appl Pharmacol</source><year>2017</year><volume>323</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2017.03.016</pub-id><?supplied-pmid 28322895?><pub-id pub-id-type="pmid">28322895</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name></person-group><article-title>Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity</article-title><source>Antiviral Res</source><year>2013</year><volume>98</volume><issue>1</issue><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.02.003</pub-id><?supplied-pmid 23422646?><pub-id pub-id-type="pmid">23422646</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>CH</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>YQ</given-names></name><name><surname>Zhao</surname><given-names>LX</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name></person-group><article-title>Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives</article-title><source>Chem Pharm Bull (Tokyo)</source><year>2014</year><volume>62</volume><issue>8</issue><fpage>764</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1248/cpb.c14-00088</pub-id><pub-id pub-id-type="pmid">25087628</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakay-Rones</surname><given-names>Z</given-names></name><name><surname>Varsano</surname><given-names>N</given-names></name><name><surname>Zlotnik</surname><given-names>M</given-names></name><name><surname>Manor</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>L</given-names></name><name><surname>Schlesinger</surname><given-names>M</given-names></name><name><surname>Mumcuoglu</surname><given-names>M</given-names></name></person-group><article-title>Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama</article-title><source>J Altern Complement Med</source><year>1995</year><volume>1</volume><issue>4</issue><fpage>361</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1089/acm.1995.1.361</pub-id><?supplied-pmid 9395631?><pub-id pub-id-type="pmid">9395631</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawitz</surname><given-names>C</given-names></name><name><surname>Mraheil</surname><given-names>MA</given-names></name><name><surname>Stein</surname><given-names>M</given-names></name><name><surname>Imirzalioglu</surname><given-names>C</given-names></name><name><surname>Domann</surname><given-names>E</given-names></name><name><surname>Pleschka</surname><given-names>S</given-names></name><name><surname>Hain</surname><given-names>T</given-names></name></person-group><article-title>Inhibitory activity of a standardized elderberry liquid extract against clinically relevant human respiratory bacterial pathogens and influenza A and B viruses</article-title><source>BMC Complement Altern Med</source><year>2011</year><volume>11</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-11-16</pub-id><?supplied-pmid 21352539?><pub-id pub-id-type="pmid">21352539</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakay-Rones</surname><given-names>Z</given-names></name><name><surname>Thom</surname><given-names>E</given-names></name><name><surname>Wollan</surname><given-names>T</given-names></name><name><surname>Wadstein</surname><given-names>J</given-names></name></person-group><article-title>Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections</article-title><source>J Int Med Res</source><year>2004</year><volume>32</volume><issue>2</issue><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1177/147323000403200205</pub-id><?supplied-pmid 15080016?><pub-id pub-id-type="pmid">15080016</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Xin</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name></person-group><article-title>Self-nanoemulsifying drug delivery systems of myricetin: formulation development, characterization, and in vitro and in vivo evaluation</article-title><source>Colloids Surf B Biointerfaces</source><year>2017</year><volume>160</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2017.09.020</pub-id><?supplied-pmid 28917148?><pub-id pub-id-type="pmid">28917148</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name></person-group><article-title>Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin</article-title><source>Eur J Pharm Sci</source><year>2016</year><volume>91</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2016.06.014</pub-id><?supplied-pmid 27328876?><pub-id pub-id-type="pmid">27328876</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>XJ</given-names></name><name><surname>Huang</surname><given-names>KM</given-names></name><name><surname>Gui</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Lu</surname><given-names>JT</given-names></name><name><surname>Dai</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells</article-title><source>Int J Nanomedicine</source><year>2016</year><volume>11</volume><fpage>4991</fpage><lpage>5002</lpage><pub-id pub-id-type="doi">10.2147/IJN.S114302</pub-id><?supplied-pmid 27757032?><pub-id pub-id-type="pmid">27757032</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Dang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name></person-group><article-title>Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation</article-title><source>Int J Pharm</source><year>2014</year><volume>477</volume><issue>1-2</issue><fpage>251</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.10.044</pub-id><?supplied-pmid 25445518?><pub-id pub-id-type="pmid">25445518</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name></person-group><article-title>A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram</article-title><source>Pharm Res</source><year>2015</year><volume>32</volume><issue>1</issue><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/s11095-014-1443-y</pub-id><?supplied-pmid 24939640?><pub-id pub-id-type="pmid">24939640</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Basak</surname><given-names>S</given-names></name></person-group><article-title>Effect of beta-cyclodextrin on the molecular properties of myricetin upon nano-encapsulation: insight from optical spectroscopy and quantum chemical studies</article-title><source>Carbohydr Polym</source><year>2014</year><volume>99</volume><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2013.08.008</pub-id><?supplied-pmid 24274487?><pub-id pub-id-type="pmid">24274487</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Cho</surname><given-names>AR</given-names></name><name><surname>Park</surname><given-names>DJ</given-names></name></person-group><article-title>Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: in vitro and in vivo evaluations</article-title><source>Food Chem</source><year>2016</year><volume>206</volume><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.03.052</pub-id><?supplied-pmid 27041302?><pub-id pub-id-type="pmid">27041302</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>A pH-sensitive microemulsion-filled gellan gum hydrogel encapsulated apigenin: Characterization and in vitro release kinetics</article-title><source>Colloids Surf B Biointerfaces</source><year>2019</year><volume>178</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2019.03.015</pub-id><?supplied-pmid 30875583?><pub-id pub-id-type="pmid">30875583</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshehri</surname><given-names>SM</given-names></name><name><surname>Shakeel</surname><given-names>F</given-names></name><name><surname>Ibrahim</surname><given-names>MA</given-names></name><name><surname>Elzayat</surname><given-names>EM</given-names></name><name><surname>Altamimi</surname><given-names>M</given-names></name><name><surname>Mohsin</surname><given-names>K</given-names></name><name><surname>Almeanazel</surname><given-names>OT</given-names></name><name><surname>Alkholief</surname><given-names>M</given-names></name><name><surname>Alshetaili</surname><given-names>A</given-names></name><name><surname>Alsulays</surname><given-names>B</given-names></name><name><surname>Alanazi</surname><given-names>FK</given-names></name><name><surname>Alsarra</surname><given-names>IA</given-names></name></person-group><article-title>Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques</article-title><source>Saudi Pharm J</source><year>2019</year><volume>27</volume><issue>2</issue><fpage>264</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2018.11.008</pub-id><?supplied-pmid 30766439?><pub-id pub-id-type="pmid">30766439</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>SM</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>XD</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>XB</given-names></name></person-group><article-title>Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion</article-title><source>Int J Nanomedicine</source><year>2014</year><volume>9</volume><fpage>2327</fpage><lpage>2333</lpage><pub-id pub-id-type="doi">10.2147/IJN.S60938</pub-id><?supplied-pmid 24872695?><pub-id pub-id-type="pmid">24872695</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name></person-group><article-title>Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system</article-title><source>Drug Dev Ind Pharm</source><year>2017</year><volume>43</volume><issue>8</issue><fpage>1276</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1080/03639045.2017.1313857</pub-id><?supplied-pmid 28358225?><pub-id pub-id-type="pmid">28358225</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telange</surname><given-names>DR</given-names></name><name><surname>Patil</surname><given-names>AT</given-names></name><name><surname>Pethe</surname><given-names>AM</given-names></name><name><surname>Fegade</surname><given-names>H</given-names></name><name><surname>Anand</surname><given-names>S</given-names></name><name><surname>Dave</surname><given-names>VS</given-names></name></person-group><article-title>Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential</article-title><source>Eur J Pharm Sci</source><year>2017</year><volume>108</volume><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2016.12.009</pub-id><?supplied-pmid 27939619?><pub-id pub-id-type="pmid">27939619</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papay</surname><given-names>ZE</given-names></name><name><surname>Kallai-Szabo</surname><given-names>N</given-names></name><name><surname>Balogh</surname><given-names>E</given-names></name><name><surname>Ludanyi</surname><given-names>K</given-names></name><name><surname>Klebovich</surname><given-names>I</given-names></name><name><surname>Antal</surname><given-names>I</given-names></name></person-group><article-title>Controlled release oral delivery of apigenin containing pellets with antioxidant activity</article-title><source>Curr Drug Deliv</source><year>2017</year><volume>14</volume><issue>1</issue><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.2174/1567201813666160602193047</pub-id><?supplied-pmid 27264725?><pub-id pub-id-type="pmid">27264725</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>Design and evaluation of a self-microemulsifying drug delivery system for apigenin</article-title><source>Drug Dev Ind Pharm</source><year>2013</year><volume>39</volume><issue>5</issue><fpage>662</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.3109/03639045.2012.687378</pub-id><?supplied-pmid 22607130?><pub-id pub-id-type="pmid">22607130</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name></person-group><article-title>Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes</article-title><source>Int J Nanomedicine</source><year>2014</year><volume>9</volume><fpage>3623</fpage><lpage>3630</lpage><pub-id pub-id-type="doi">10.2147/IJN.S66312</pub-id><?supplied-pmid 25120360?><pub-id pub-id-type="pmid">25120360</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery</article-title><source>Drug Deliv</source><year>2016</year><volume>23</volume><issue>6</issue><fpage>1933</fpage><lpage>1939</lpage><pub-id pub-id-type="doi">10.3109/10717544.2015.1008705</pub-id><?supplied-pmid 25693642?><pub-id pub-id-type="pmid">25693642</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>Preparation, optimization, characterization and cytotoxicity in vitro of baicalin-loaded mixed micelles</article-title><source>J Colloid Interface Sci</source><year>2014</year><volume>434</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2014.07.045</pub-id><?supplied-pmid 25168581?><pub-id pub-id-type="pmid">25168581</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name></person-group><article-title>Enhanced efficacy of baicalin-loaded TPGS polymeric micelles against periodontitis</article-title><source>Mater Sci Eng C Mater Biol Appl</source><year>2019</year><volume>101</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.msec.2019.03.103</pub-id><?supplied-pmid 31029332?><pub-id pub-id-type="pmid">31029332</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakab</surname><given-names>G</given-names></name><name><surname>Fulop</surname><given-names>V</given-names></name><name><surname>Bozo</surname><given-names>T</given-names></name><name><surname>Balogh</surname><given-names>E</given-names></name><name><surname>Kellermayer</surname><given-names>M</given-names></name><name><surname>Antal</surname><given-names>I</given-names></name></person-group><article-title>Optimization of quality attributes and atomic force microscopy imaging of reconstituted nanodroplets in baicalin loaded self-nanoemulsifying formulations</article-title><source>Pharmaceutics</source><year>2018</year><volume>10</volume><issue>4</issue><fpage>E275</fpage><pub-id pub-id-type="doi">10.3390/pharmaceutics10040275</pub-id><?supplied-pmid 30551629?><pub-id pub-id-type="pmid">30551629</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group><article-title>Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure</article-title><source>Drug Dev Ind Pharm</source><year>2018</year><volume>44</volume><issue>2</issue><fpage>266</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1080/03639045.2017.1391831</pub-id><?supplied-pmid 29022400?><pub-id pub-id-type="pmid">29022400</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>The formation of a host-guest inclusion complex system between beta-cyclodextrin and baicalin and its dissolution characteristics</article-title><source>J Pharm Pharmacol</source><year>2017</year><volume>69</volume><issue>6</issue><fpage>663</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1111/jphp.12708</pub-id><?supplied-pmid 28299800?><pub-id pub-id-type="pmid">28299800</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Sune</surname><given-names>E</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>XB</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name></person-group><article-title>Characterization and bioavailability study of baicalin-mesoporous carbon nanopowder solid dispersion</article-title><source>Pharmacogn Mag</source><year>2016</year><volume>12</volume><issue>48</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.4103/0973-1296.192199</pub-id><?supplied-pmid 27867277?><pub-id pub-id-type="pmid">27867277</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Okeke</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>N</given-names></name></person-group><article-title>Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB</article-title><source>Drug Dev Ind Pharm</source><year>2015</year><volume>41</volume><issue>3</issue><fpage>353</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.3109/03639045.2013.861478</pub-id><?supplied-pmid 25784073?><pub-id pub-id-type="pmid">25784073</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi-Ying</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Shi-Xiao</surname><given-names>J</given-names></name><name><surname>Qing-Yuan</surname><given-names>L</given-names></name><name><surname>Jin-Xia</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>HG</given-names></name><name><surname>Rui-Sheng</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Hai-Long</surname><given-names>Y</given-names></name></person-group><article-title>Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method</article-title><source>Chin J Nat Med</source><year>2014</year><volume>12</volume><issue>1</issue><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/S1875-5364(14)60012-1</pub-id><?supplied-pmid 24484600?><pub-id pub-id-type="pmid">24484600</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name></person-group><article-title>Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal</article-title><source>Int J Pharm</source><year>2011</year><volume>420</volume><issue>1</issue><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2011.08.023</pub-id><?supplied-pmid 21878378?><pub-id pub-id-type="pmid">21878378</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Preparation and evaluation of self-microemulsifying drug delivery system of baicalein</article-title><source>Fitoterapia</source><year>2012</year><volume>83</volume><issue>8</issue><fpage>1532</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.08.021</pub-id><?supplied-pmid 22982454?><pub-id pub-id-type="pmid">22982454</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>F</given-names></name><name><surname>Franceschini</surname><given-names>I</given-names></name><name><surname>Corrias</surname><given-names>F</given-names></name><name><surname>Sala</surname><given-names>MC</given-names></name><name><surname>Cilurzo</surname><given-names>F</given-names></name><name><surname>Sinico</surname><given-names>C</given-names></name><name><surname>Pini</surname><given-names>E</given-names></name></person-group><article-title>Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study</article-title><source>Carbohydr Polym</source><year>2015</year><volume>121</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2014.11.070</pub-id><?supplied-pmid 25659692?><pub-id pub-id-type="pmid">25659692</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aluani</surname><given-names>D</given-names></name><name><surname>Tzankova</surname><given-names>V</given-names></name><name><surname>Kondeva-Burdina</surname><given-names>M</given-names></name><name><surname>Yordanov</surname><given-names>Y</given-names></name><name><surname>Nikolova</surname><given-names>E</given-names></name><name><surname>Odzhakov</surname><given-names>F</given-names></name><name><surname>Apostolov</surname><given-names>A</given-names></name><name><surname>Markova</surname><given-names>T</given-names></name><name><surname>Yoncheva</surname><given-names>K</given-names></name></person-group><article-title>Capital IE, Cyrillic valuation of biocompatibility and antioxidant efficiency of chitosan-alginate nanoparticles loaded with quercetin</article-title><source>Int J Biol Macromol</source><year>2017</year><volume>103</volume><fpage>771</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.05.062</pub-id><?supplied-pmid 28536020?><pub-id pub-id-type="pmid">28536020</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwer</surname><given-names>MK</given-names></name><name><surname>Al-Mansoor</surname><given-names>MA</given-names></name><name><surname>Jamil</surname><given-names>S</given-names></name><name><surname>Al-Shdefat</surname><given-names>R</given-names></name><name><surname>Ansari</surname><given-names>MN</given-names></name><name><surname>Shakeel</surname><given-names>F</given-names></name></person-group><article-title>Development and evaluation of PLGA polymer based nanoparticles of quercetin</article-title><source>Int J Biol Macromol</source><year>2016</year><volume>92</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.07.002</pub-id><?supplied-pmid 27381585?><pub-id pub-id-type="pmid">27381585</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagad</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>ZA</given-names></name></person-group><article-title>Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats</article-title><source>Int J Nanomedicine</source><year>2015</year><volume>10</volume><fpage>3921</fpage><lpage>3935</lpage><pub-id pub-id-type="doi">10.2147/IJN.S80706</pub-id><?supplied-pmid 26089668?><pub-id pub-id-type="pmid">26089668</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>AI</given-names></name><name><surname>Costa Lima</surname><given-names>SA</given-names></name><name><surname>Reis</surname><given-names>S</given-names></name></person-group><article-title>Application of pH-responsive fucoidan/chitosan nanoparticles to improve oral quercetin delivery</article-title><source>Molecules</source><year>2019</year><volume>24</volume><issue>2</issue><fpage>E346</fpage><pub-id pub-id-type="doi">10.3390/molecules24020346</pub-id><?supplied-pmid 30669398?><pub-id pub-id-type="pmid">30669398</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedaghat Doost</surname><given-names>A</given-names></name><name><surname>Kassozi</surname><given-names>V</given-names></name><name><surname>Grootaert</surname><given-names>C</given-names></name><name><surname>Claeys</surname><given-names>M</given-names></name><name><surname>Dewettinck</surname><given-names>K</given-names></name><name><surname>Van Camp</surname><given-names>J</given-names></name><name><surname>Van der Meeren</surname><given-names>P</given-names></name></person-group><article-title>Self-assembly, functionality, and in-vitro properties of quercetin loaded nanoparticles based on shellac-almond gum biological macromolecules</article-title><source>Int J Biol Macromol</source><year>2019</year><volume>129</volume><fpage>1024</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.02.071</pub-id><?supplied-pmid 30794898?><pub-id pub-id-type="pmid">30794898</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>A</given-names></name><name><surname>Ronchi</surname><given-names>M</given-names></name><name><surname>Petrangolini</surname><given-names>G</given-names></name><name><surname>Bosisio</surname><given-names>S</given-names></name><name><surname>Allegrini</surname><given-names>P</given-names></name></person-group><article-title>Improved oral absorption of quercetin from quercetin phytosome(R), a new delivery system based on food grade lecithin</article-title><source>Eur J Drug Metab Pharmacokinet</source><year>2019</year><volume>44</volume><issue>2</issue><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1007/s13318-018-0517-3</pub-id><?supplied-pmid 30328058?><pub-id pub-id-type="pmid">30328058</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>EB</given-names></name><name><surname>Almeda</surname><given-names>RA</given-names></name><name><surname>Vidallon</surname><given-names>MLP</given-names></name><name><surname>Reyes</surname><given-names>CT</given-names></name></person-group><article-title>Enhanced bioactivity and efficient delivery of quercetin through nanoliposomal encapsulation using rice bran phospholipids</article-title><source>J Sci Food Agric</source><year>2019</year><volume>99</volume><issue>4</issue><fpage>1980</fpage><lpage>1989</lpage><pub-id pub-id-type="doi">10.1002/jsfa.9396</pub-id><?supplied-pmid 30270448?><pub-id pub-id-type="pmid">30270448</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Bu</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery</article-title><source>Biosci Biotechnol Biochem</source><year>2018</year><volume>82</volume><issue>2</issue><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1080/09168451.2017.1419852</pub-id><?supplied-pmid 29327653?><pub-id pub-id-type="pmid">29327653</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>Pharmacokinetics of quercetin-loaded methoxy poly(ethylene glycol)-b-poly(L-lactic acid) micelle after oral administration in rats</article-title><source>Biomed Res Int</source><year>2017</year><volume>2017</volume><fpage>1750895</fpage><pub-id pub-id-type="doi">10.1155/2017/1750895</pub-id><?supplied-pmid 29234675?><pub-id pub-id-type="pmid">29234675</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Ahmad</surname><given-names>R</given-names></name><name><surname>Naqvi</surname><given-names>AA</given-names></name><name><surname>Alam</surname><given-names>MA</given-names></name><name><surname>Abdur Rub</surname><given-names>R</given-names></name><name><surname>Ahmad</surname><given-names>FJ</given-names></name></person-group><article-title>Enhancement of quercetin oral bioavailability by self-nanoemulsifying drug delivery system and their quantification through ultra high performance liquid chromatography and mass spectrometry in cerebral ischemia</article-title><source>Drug Res (Stuttg)</source><year>2017</year><volume>67</volume><issue>10</issue><fpage>564</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1055/s-0043-109564</pub-id><pub-id pub-id-type="pmid">28561230</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>TH</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Bruno</surname><given-names>RS</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name></person-group><article-title>Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability</article-title><source>J Pharm Sci</source><year>2014</year><volume>103</volume><issue>3</issue><fpage>840</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1002/jps.23858</pub-id><?supplied-pmid 24464737?><pub-id pub-id-type="pmid">24464737</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadrich</surname><given-names>G</given-names></name><name><surname>Monteiro</surname><given-names>SO</given-names></name><name><surname>Rodrigues</surname><given-names>MR</given-names></name><name><surname>de Lima</surname><given-names>VR</given-names></name><name><surname>Putaux</surname><given-names>JL</given-names></name><name><surname>Bidone</surname><given-names>J</given-names></name><name><surname>Teixeira</surname><given-names>HF</given-names></name><name><surname>Muccillo-Baisch</surname><given-names>AL</given-names></name><name><surname>Dora</surname><given-names>CL</given-names></name></person-group><article-title>Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies</article-title><source>Drug Dev Ind Pharm</source><year>2016</year><volume>42</volume><issue>7</issue><fpage>1165</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.3109/03639045.2015.1118491</pub-id><?supplied-pmid 26571009?><pub-id pub-id-type="pmid">26571009</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Katare</surname><given-names>OP</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name></person-group><article-title>Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences</article-title><source>Int J Pharm</source><year>2016</year><volume>515</volume><issue>1-2</issue><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.10.024</pub-id><?supplied-pmid 27756627?><pub-id pub-id-type="pmid">27756627</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadrich</surname><given-names>G</given-names></name><name><surname>Vaz</surname><given-names>GR</given-names></name><name><surname>Maidana</surname><given-names>M</given-names></name><name><surname>Kratz</surname><given-names>JM</given-names></name><name><surname>Loch-Neckel</surname><given-names>G</given-names></name><name><surname>Favarin</surname><given-names>DC</given-names></name><name><surname>Rogerio Ade</surname><given-names>P</given-names></name><name><surname>da Silva</surname><given-names>FM</given-names><suffix>Jr</suffix></name><name><surname>Muccillo-Baisch</surname><given-names>AL</given-names></name><name><surname>Dora</surname><given-names>CL</given-names></name></person-group><article-title>Anti-inflammatory effect and toxicology analysis of oral delivery quercetin nanosized emulsion in rats</article-title><source>Pharm Res</source><year>2016</year><volume>33</volume><issue>4</issue><fpage>983</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1007/s11095-015-1844-6</pub-id><?supplied-pmid 26687116?><pub-id pub-id-type="pmid">26687116</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Pei</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>A</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>Development of nanosuspension formulation for oral delivery of quercetin</article-title><source>J Biomed Nanotechnol</source><year>2010</year><volume>6</volume><issue>4</issue><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1166/jbn.2010.1133</pub-id><pub-id pub-id-type="pmid">21323105</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Shan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Di</surname><given-names>L</given-names></name></person-group><article-title>Effect of chito-oligosaccharide on the intestinal absorptions of phenylethanoid glycosides in Fructus Forsythiae extract</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><issue>12</issue><fpage>1549</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2014.06.016</pub-id><?supplied-pmid 25442264?><pub-id pub-id-type="pmid">25442264</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>A</given-names></name><name><surname>Shan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Di</surname><given-names>L</given-names></name></person-group><article-title>Study on the rationality for antiviral activity of Flos Lonicerae japonicae-fructus Forsythiae herb chito-oligosaccharide via Integral Pharmacokinetics</article-title><source>Molecules</source><year>2017</year><volume>22</volume><issue>4</issue><fpage>E654</fpage><pub-id pub-id-type="doi">10.3390/molecules22040654</pub-id><?supplied-pmid 28425933?><pub-id pub-id-type="pmid">28425933</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sermkaew</surname><given-names>N</given-names></name><name><surname>Ketjinda</surname><given-names>W</given-names></name><name><surname>Boonme</surname><given-names>P</given-names></name><name><surname>Phadoongsombut</surname><given-names>N</given-names></name><name><surname>Wiwattanapatapee</surname><given-names>R</given-names></name></person-group><article-title>Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculata</article-title><source>Eur J Pharm Sci</source><year>2013</year><volume>50</volume><issue>3-4</issue><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2013.08.006</pub-id><?supplied-pmid 23973887?><pub-id pub-id-type="pmid">23973887</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><article-title>Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation</article-title><source>Int J Pharm</source><year>2014</year><volume>475</volume><issue>1-2</issue><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.09.016</pub-id><?supplied-pmid 25219858?><pub-id pub-id-type="pmid">25219858</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Rui</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Di</surname><given-names>L</given-names></name></person-group><article-title>Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-alpha-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate</article-title><source>Int J Nanomedicine</source><year>2017</year><volume>12</volume><fpage>1033</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.2147/IJN.S120887</pub-id><?supplied-pmid 28223797?><pub-id pub-id-type="pmid">28223797</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yue</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name></person-group><article-title>Design and evaluation of novel solid self-nanodispersion delivery system for andrographolide</article-title><source>AAPS PharmSciTech</source><year>2017</year><volume>18</volume><issue>5</issue><fpage>1572</fpage><lpage>1584</lpage><pub-id pub-id-type="doi">10.1208/s12249-016-0627-7</pub-id><?supplied-pmid 27620195?><pub-id pub-id-type="pmid">27620195</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Sheng</surname><given-names>HH</given-names></name><name><surname>Feng</surname><given-names>NP</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>ZT</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name></person-group><article-title>Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity</article-title><source>J Pharm Sci</source><year>2013</year><volume>102</volume><issue>12</issue><fpage>4414</fpage><lpage>4425</lpage><pub-id pub-id-type="doi">10.1002/jps.23758</pub-id><?supplied-pmid 24166599?><pub-id pub-id-type="pmid">24166599</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>T</given-names></name></person-group><article-title>Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin</article-title><source>Pharmazie</source><year>2009</year><volume>64</volume><issue>8</issue><fpage>515</fpage><lpage>520</lpage><?supplied-pmid 19746840?><pub-id pub-id-type="pmid">19746840</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbar</surname><given-names>MU</given-names></name><name><surname>Zia</surname><given-names>KM</given-names></name><name><surname>Nazir</surname><given-names>A</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Ejaz</surname><given-names>SA</given-names></name><name><surname>Akash</surname><given-names>MSH</given-names></name></person-group><article-title>Pluronic-based mixed polymeric micelles enhance the therapeutic potential of curcumin</article-title><source>AAPS PharmSciTech</source><year>2018</year><volume>19</volume><issue>6</issue><fpage>2719</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1208/s12249-018-1098-9</pub-id><?supplied-pmid 29978290?><pub-id pub-id-type="pmid">29978290</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chu</surname><given-names>L</given-names></name><name><surname>Tong</surname><given-names>HH</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name></person-group><article-title>Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration</article-title><source>Colloids Surf B Biointerfaces</source><year>2016</year><volume>141</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.01.017</pub-id><?supplied-pmid 26874910?><pub-id pub-id-type="pmid">26874910</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramalingam</surname><given-names>P</given-names></name><name><surname>Ko</surname><given-names>YT</given-names></name></person-group><article-title>Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations</article-title><source>Pharm Res</source><year>2015</year><volume>32</volume><issue>2</issue><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1007/s11095-014-1469-1</pub-id><?supplied-pmid 25082210?><pub-id pub-id-type="pmid">25082210</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorasitthiyanukarn</surname><given-names>FN</given-names></name><name><surname>Ratnatilaka Na Bhuket</surname><given-names>P</given-names></name><name><surname>Muangnoi</surname><given-names>C</given-names></name><name><surname>Rojsitthisak</surname><given-names>P</given-names></name><name><surname>Rojsitthisak</surname><given-names>P</given-names></name></person-group><article-title>Chitosan/alginate nanoparticles as a promising carrier of novel curcumin diethyl diglutarate</article-title><source>Int J Biol Macromol</source><year>2019</year><volume>131</volume><fpage>1125</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.03.120</pub-id><?supplied-pmid 30902713?><pub-id pub-id-type="pmid">30902713</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Xin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin</article-title><source>Int J Nanomedicine</source><year>2019</year><volume>14</volume><fpage>557</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.2147/IJN.S191337</pub-id><?supplied-pmid 30666114?><pub-id pub-id-type="pmid">30666114</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine</article-title><source>Int J Pharm</source><year>2019</year><volume>561</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2019.02.027</pub-id><?supplied-pmid 30817985?><pub-id pub-id-type="pmid">30817985</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazari-Vanani</surname><given-names>R</given-names></name><name><surname>Moezi</surname><given-names>L</given-names></name><name><surname>Heli</surname><given-names>H</given-names></name></person-group><article-title>In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>88</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.01.102</pub-id><?supplied-pmid 28152481?><pub-id pub-id-type="pmid">28152481</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaisamut</surname><given-names>P</given-names></name><name><surname>Wiwattanawongsa</surname><given-names>K</given-names></name><name><surname>Graidist</surname><given-names>P</given-names></name><name><surname>Sangsen</surname><given-names>Y</given-names></name><name><surname>Wiwattanapatapee</surname><given-names>R</given-names></name></person-group><article-title>Enhanced oral bioavailability of curcumin using a supersaturatable self-microemulsifying system incorporating a hydrophilic polymer; in vitro and in vivo investigations</article-title><source>AAPS PharmSciTech</source><year>2018</year><volume>19</volume><issue>2</issue><fpage>730</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1208/s12249-017-0857-3</pub-id><?supplied-pmid 28975598?><pub-id pub-id-type="pmid">28975598</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Asghar</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Ping</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name></person-group><article-title>Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers</article-title><source>Int J Nanomedicine</source><year>2017</year><volume>12</volume><fpage>7897</fpage><lpage>7911</lpage><pub-id pub-id-type="doi">10.2147/IJN.S145988</pub-id><?supplied-pmid 29138557?><pub-id pub-id-type="pmid">29138557</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheiri Manjili</surname><given-names>H</given-names></name><name><surname>Ghasemi</surname><given-names>P</given-names></name><name><surname>Malvandi</surname><given-names>H</given-names></name><name><surname>Mousavi</surname><given-names>MS</given-names></name><name><surname>Attari</surname><given-names>E</given-names></name><name><surname>Danafar</surname><given-names>H</given-names></name></person-group><article-title>Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles</article-title><source>Eur J Pharm Biopharm</source><year>2017</year><volume>116</volume><fpage>17</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2016.10.003</pub-id><?supplied-pmid 27756682?><pub-id pub-id-type="pmid">27756682</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aqil</surname><given-names>F</given-names></name><name><surname>Munagala</surname><given-names>R</given-names></name><name><surname>Jeyabalan</surname><given-names>J</given-names></name><name><surname>Agrawal</surname><given-names>AK</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name></person-group><article-title>Exosomes for the enhanced tissue bioavailability and efficacy of curcumin</article-title><source>AAPS J</source><year>2017</year><volume>19</volume><issue>6</issue><fpage>1691</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1208/s12248-017-0154-9</pub-id><?supplied-pmid 29047044?><pub-id pub-id-type="pmid">29047044</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AW</given-names></name><name><surname>Kotta</surname><given-names>S</given-names></name><name><surname>Ansari</surname><given-names>SH</given-names></name><name><surname>Sharma</surname><given-names>RK</given-names></name><name><surname>Ali</surname><given-names>J</given-names></name></person-group><article-title>Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation</article-title><source>Drug Deliv</source><year>2015</year><volume>22</volume><issue>4</issue><fpage>552</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.3109/10717544.2013.878003</pub-id><?supplied-pmid 24512268?><pub-id pub-id-type="pmid">24512268</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AW</given-names></name><name><surname>Kotta</surname><given-names>S</given-names></name><name><surname>Ansari</surname><given-names>SH</given-names></name><name><surname>Sharma</surname><given-names>RK</given-names></name><name><surname>Ali</surname><given-names>J</given-names></name></person-group><article-title>Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier</article-title><source>Drug Dev Ind Pharm</source><year>2015</year><volume>41</volume><issue>5</issue><fpage>772</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.3109/03639045.2014.902466</pub-id><?supplied-pmid 24669978?><pub-id pub-id-type="pmid">24669978</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaurasia</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>RR</given-names></name><name><surname>Vure</surname><given-names>P</given-names></name><name><surname>Mishra</surname><given-names>B</given-names></name></person-group><article-title>Potential of cationic-polymeric nanoparticles for oral delivery of naringenin: in vitro and in vivo investigations</article-title><source>J Pharm Sci</source><year>2018</year><volume>107</volume><issue>2</issue><fpage>706</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/j.xphs.2017.10.006</pub-id><?supplied-pmid 29031951?><pub-id pub-id-type="pmid">29031951</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics</article-title><source>Drug Des Devel Ther</source><year>2016</year><volume>10</volume><fpage>911</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S97738</pub-id><?supplied-pmid 27041995?><pub-id pub-id-type="pmid">27041995</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Firempong</surname><given-names>CK</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations</article-title><source>AAPS PharmSciTech</source><year>2017</year><volume>18</volume><issue>3</issue><fpage>586</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1208/s12249-016-0537-8</pub-id><?supplied-pmid 27151135?><pub-id pub-id-type="pmid">27151135</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gera</surname><given-names>S</given-names></name><name><surname>Talluri</surname><given-names>S</given-names></name><name><surname>Rangaraj</surname><given-names>N</given-names></name><name><surname>Sampathi</surname><given-names>S</given-names></name></person-group><article-title>Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement</article-title><source>AAPS PharmSciTech</source><year>2017</year><volume>18</volume><issue>8</issue><fpage>3151</fpage><lpage>3162</lpage><pub-id pub-id-type="doi">10.1208/s12249-017-0790-5</pub-id><?supplied-pmid 28534300?><pub-id pub-id-type="pmid">28534300</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>MK</given-names></name><name><surname>Pooja</surname><given-names>D</given-names></name><name><surname>Ravuri</surname><given-names>HG</given-names></name><name><surname>Gunukula</surname><given-names>A</given-names></name><name><surname>Kulhari</surname><given-names>H</given-names></name><name><surname>Sistla</surname><given-names>R</given-names></name></person-group><article-title>Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability</article-title><source>Phytomedicine</source><year>2018</year><volume>40</volume><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2017.12.021</pub-id><?supplied-pmid 29496174?><pub-id pub-id-type="pmid">29496174</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Soto-Gutierrez</surname><given-names>A</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Goldwasser</surname><given-names>J</given-names></name><name><surname>Lee-Parsons</surname><given-names>CW</given-names></name><name><surname>Benny-Ratsaby</surname><given-names>O</given-names></name><name><surname>Yarmush</surname><given-names>ML</given-names></name><name><surname>Nahmias</surname><given-names>Y</given-names></name></person-group><article-title>Enhancement of naringenin bioavailability by complexation with hydroxypropyl-beta-cyclodextrin. [corrected]</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>4</issue><fpage>e18033</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0018033</pub-id><?supplied-pmid 21494673?><pub-id pub-id-type="pmid">21494673</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Investigation of inclusion complex of honokiol with sulfobutyl ether-beta-cyclodextrin</article-title><source>Carbohydr Polym</source><year>2014</year><volume>113</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2014.06.059</pub-id><?supplied-pmid 25256452?><pub-id pub-id-type="pmid">25256452</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>N</given-names></name><name><surname>Cai</surname><given-names>LL</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name></person-group><article-title>Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles</article-title><source>Biomed Mater</source><year>2010</year><volume>5</volume><issue>6</issue><fpage>065006</fpage><pub-id pub-id-type="doi">10.1088/1748-6041/5/6/065006</pub-id><?supplied-pmid 20966535?><pub-id pub-id-type="pmid">20966535</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gou</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Men</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Luo</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>Z</given-names></name></person-group><article-title>Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro</article-title><source>Int J Pharm</source><year>2009</year><volume>375</volume><issue>1-2</issue><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.04.007</pub-id><?supplied-pmid 19427143?><pub-id pub-id-type="pmid">19427143</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Dou</surname><given-names>J</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>L</given-names></name></person-group><article-title>Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation</article-title><source>Int J Nanomedicine</source><year>2013</year><volume>8</volume><fpage>2917</fpage><lpage>2926</lpage><pub-id pub-id-type="doi">10.2147/IJN.S47510</pub-id><?supplied-pmid 23966781?><pub-id pub-id-type="pmid">23966781</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles</article-title><source>Drug Des Devel Ther</source><year>2017</year><volume>11</volume><fpage>1417</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S133997</pub-id><?supplied-pmid 28533680?><pub-id pub-id-type="pmid">28533680</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Ng</surname><given-names>KY</given-names></name><name><surname>Heng</surname><given-names>PW</given-names></name></person-group><article-title>Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid</article-title><source>Pharm Res</source><year>2011</year><volume>28</volume><issue>8</issue><fpage>2020</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1007/s11095-011-0428-3</pub-id><?supplied-pmid 21479757?><pub-id pub-id-type="pmid">21479757</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Ng</surname><given-names>KY</given-names></name><name><surname>Heng</surname><given-names>PW</given-names></name></person-group><article-title>Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments</article-title><source>Biol Pharm Bull</source><year>2014</year><volume>37</volume><issue>6</issue><fpage>926</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1248/bpb.b13-00864</pub-id><pub-id pub-id-type="pmid">24882406</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>Q</given-names></name><name><surname>Chan</surname><given-names>CK</given-names></name><name><surname>Meng</surname><given-names>ZY</given-names></name><name><surname>Wang</surname><given-names>GN</given-names></name><name><surname>Sun</surname><given-names>JB</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Tong</surname><given-names>HH</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group><article-title>Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid</article-title><source>AAPS PharmSciTech</source><year>2009</year><volume>10</volume><issue>1</issue><fpage>172</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1208/s12249-009-9190-9</pub-id><?supplied-pmid 19224372?><pub-id pub-id-type="pmid">19224372</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Asghar</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Kambere Amerigos</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Ping</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name></person-group><article-title>N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations</article-title><source>Drug Deliv</source><year>2017</year><volume>24</volume><issue>1</issue><fpage>1605</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1080/10717544.2017.1391890</pub-id><?supplied-pmid 29063815?><pub-id pub-id-type="pmid">29063815</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouton</surname><given-names>CW</given-names></name><name><surname>Porter</surname><given-names>CJ</given-names></name></person-group><article-title>Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies</article-title><source>Adv Drug Deliv Rev</source><year>2008</year><volume>60</volume><issue>6</issue><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2007.10.010</pub-id><?supplied-pmid 18068260?><pub-id pub-id-type="pmid">18068260</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><mixed-citation publication-type="other">McClements DJ (2018) Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals. Biotechnol Adv. 10.1016/j.biotechadv.2018.08.004</mixed-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Lalani</surname><given-names>R</given-names></name><name><surname>Bardoliwala</surname><given-names>D</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Misra</surname><given-names>A</given-names></name></person-group><article-title>Lipid-based oral formulation strategies for lipophilic drugs</article-title><source>AAPS PharmSciTech</source><year>2018</year><volume>19</volume><issue>8</issue><fpage>3609</fpage><lpage>3630</lpage><pub-id pub-id-type="doi">10.1208/s12249-018-1188-8</pub-id><?supplied-pmid 30255474?><pub-id pub-id-type="pmid">30255474</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>A</given-names></name></person-group><article-title>The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats</article-title><source>Eur J Pharm Biopharm</source><year>2007</year><volume>67</volume><issue>1</issue><fpage>96</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2007.01.017</pub-id><?supplied-pmid 17329087?><pub-id pub-id-type="pmid">17329087</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>A</given-names></name></person-group><article-title>Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs</article-title><source>J Control Release</source><year>2008</year><volume>129</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2008.03.021</pub-id><?supplied-pmid 18499294?><pub-id pub-id-type="pmid">18499294</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beig</surname><given-names>A</given-names></name><name><surname>Agbaria</surname><given-names>R</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>The use of captisol (SBE7-beta-CD) in oral solubility-enabling formulations: comparison to HPbetaCD and the solubility-permeability interplay</article-title><source>Eur J Pharm Sci</source><year>2015</year><volume>77</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2015.05.024</pub-id><?supplied-pmid 26006306?><pub-id pub-id-type="pmid">26006306</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beig</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>JM</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off</article-title><source>Eur J Pharm Biopharm</source><year>2013</year><volume>85</volume><issue>3 Pt B</issue><fpage>1293</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2013.05.018</pub-id><?supplied-pmid 23770429?><pub-id pub-id-type="pmid">23770429</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JM</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation</article-title><source>Int J Pharm</source><year>2012</year><volume>430</volume><issue>1-2</issue><fpage>388</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.03.017</pub-id><?supplied-pmid 22465550?><pub-id pub-id-type="pmid">22465550</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amidon</surname><given-names>GE</given-names></name><name><surname>Higuchi</surname><given-names>WI</given-names></name><name><surname>Ho</surname><given-names>NF</given-names></name></person-group><article-title>Theoretical and experimental studies of transport of micelle-solubilized solutes</article-title><source>J Pharm Sci</source><year>1982</year><volume>71</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/jps.2600710120</pub-id><?supplied-pmid 7057387?><pub-id pub-id-type="pmid">7057387</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beig</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>JM</given-names></name><name><surname>Lindley</surname><given-names>D</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>Striking the optimal solubility-permeability balance in oral formulation development for lipophilic drugs: maximizing Carbamazepine blood levels</article-title><source>Mol Pharm</source><year>2017</year><volume>14</volume><issue>1</issue><fpage>319</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.6b00967</pub-id><?supplied-pmid 27981848?><pub-id pub-id-type="pmid">27981848</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine-Shamir</surname><given-names>N</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>Methacrylate-copolymer Eudragit EPO as a solubility-enabling excipient for anionic drugs: investigation of drug solubility, intestinal permeability, and their interplay</article-title><source>Mol Pharm</source><year>2019</year><volume>16</volume><issue>7</issue><fpage>2884</fpage><lpage>2891</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.9b00057</pub-id><?supplied-pmid 31120762?><pub-id pub-id-type="pmid">31120762</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beig</surname><given-names>A</given-names></name><name><surname>Lindley</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>JM</given-names></name><name><surname>Agbaria</surname><given-names>R</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name></person-group><article-title>Hydrotropic solubilization of lipophilic drugs for oral delivery: the effects of urea and nicotinamide on carbamazepine solubility-permeability interplay</article-title><source>Front Pharmacol</source><year>2016</year><volume>7</volume><fpage>379</fpage><pub-id pub-id-type="doi">10.3389/fphar.2016.00379</pub-id><?supplied-pmid 27826241?><pub-id pub-id-type="pmid">27826241</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>Beig</surname><given-names>A</given-names></name><name><surname>Lindley</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>JM</given-names></name></person-group><article-title>The solubility-permeability interplay and oral drug formulation design: two heads are better than one</article-title><source>Adv Drug Deliv Rev</source><year>2016</year><volume>101</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2016.04.018</pub-id><?supplied-pmid 27129443?><pub-id pub-id-type="pmid">27129443</pub-id></element-citation></ref></ref-list></back></article>